THE IMPACT OF TYPE 2 DIABETES MELLITUS ON SYMPTOM PRESENTATION AND RESPONSE TO TREATMENT IN INDIVIDUALS WITH BENIGN PAROXYSMAL POSITIONAL VERTIGO by D'Silva, Linda Joan
THE IMPACT OF TYPE 2 DIABETES MELLITUS ON SYMPTOM PRESENTATION AND 
RESPONSE TO TREATMENT IN INDIVIDUALS WITH BENIGN PAROXYSMAL 
POSITIONAL VERTIGO 
BY 
Linda Joan D’Silva 
MSPT, University of Mumbai, 1990  
BSPT, University of Mumbai, 1987 
 
Submitted to the graduate degree program in Rehabilitation Science and the Graduate faculty of 



































The Dissertation Committee for Linda Joan D’Silva  




THE IMPACT OF TYPE 2 DIABETES MELLITUS ON SYMPTOM PRESENTATION AND 
























Diabetic complications, such as retinopathy and peripheral neuropathy, have been studied 
extensively and are known to impair balance and increase fall risk. However, the effect of 
diabetes on the vestibular system is not clear. The vestibular system plays an important role in 
maintaining static and dynamic balance, by providing spatially orienting information. Hence, 
damage to the vestibular system could potentially increase imbalance and risk of falls. The 
primary purpose of this work was to examine the effect of diabetes on the peripheral vestibular 
system, and the resulting impact on symptoms, mobility and balance. 
In Chapter 1, we have presented a review of the literature on the pathophysiology of 
diabetes-related complications and their influence on balance and falls, with specific attention to 
emerging evidence of vestibular dysfunction due to diabetes. We have provided a perspective on 
the impact of vestibular complications, the need for a thorough vestibular evaluation, and 
recommendations for vestibular rehabilitation techniques, for people with diabetes.  
Chapter 2 describes the results of our pilot investigation, where we focused our attention 
to identify if a specific vestibular disorder may be present in higher frequency in individuals with 
type 2 diabetes (T2D).  In this retrospective analysis of electronic health records, we examined 
data from 3933 individuals with nine common vestibular disorders. Of the nine vestibular 
disorders commonly seen in the clinic setting, the prevalence of one condition, benign 
paroxysmal positional vertigo (BPPV), was significantly higher in individuals with diabetes. 
Factors that were predictive of BPPV included age, female sex, race and presence of 
hypertension. Hypertension was the mediating factor that increased the prevalence of BPPV in 
people with diabetes. Building upon this study, we identified benign paroxysmal positional 
iv 
 
vertigo as our clinical condition of interest. We developed our specific aims to examine the direct 
effect of diabetes on the vestibular system using evoked potential studies, as well as the indirect 
effects on symptoms, mobility and balance, in people diagnosed with BPPV.    
Chapter 2 showed that the prevalence of BPPV was higher in people with diabetes. BPPV 
results when otoconia fragments dislodge from the otolith organs of the inner ear, and cause 
symptoms of vertigo. The effect of diabetes on the saccule and utricle of the vestibular system is 
not clear, and the combined effect of BPPV and diabetes on the otolith organs, has not been 
studied. In Chapter 3, our main purpose was to analyze otolith function using vestibular evoked 
myogenic potential (VEMP) tests in people with diabetes and concurrent BPPV, and to examine 
the relationships between VEMP variables and diabetes-related variables. For this study, we 
recruited people who were 40 to 65 years of age, into four groups; 20 controls, 19 individuals 
with T2D without vestibular dysfunction, 18 individuals with BPPV, and 14 individuals with 
BPPV and diabetes (BPPV+DM). Results of this study showed that the frequency of delayed and 
absent saccule responses was significantly higher in people with T2D, BPPV, and BPPV+DM 
compared to healthy controls. Delayed latency of the saccule responses were associated with 
higher HbA1c levels. Utricle function did not appear to be as affected by diabetes as the saccule. 
Although, BPPV and diabetes independently affected utricle and saccule function, they did not 
appear to have a distinct cumulative effect.   
The true impact of a disease is the resulting impairment to the affected individual, and the 
effect on daily activities. Chapter 3 revealed otolith dysfunction in people with T2D, BPPV and 
BPPV+DM. Because otolith dysfunction is associated with balance deficits and increased 
postural sway, in chapter 4, we examined postural sway. In this study, we compared the postural 
sway of people with BPPV and BPPV+DM who were between 40 to 65 years of age. We 
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expanded the scope of our data collection to include healthy controls and people with diabetes 
(without vestibular dysfunction) for comparison with BPPV and BPPV+DM, as normative 
values for postural sway using the specific accelerometry procedures and conditions we tested is 
not available. Not all participants from chapter 3 were included in this study due to equipment 
malfunction and other issues. Ultimately, we recruited 14 controls, 14 individuals with T2D 
only, 13 individuals with BPPV only and 11 individuals with BPPV+DM for this study. We 
measured postural sway using an accelerometer positioned over the L3 spine level, in five 
conditions that progressively challenged the vestibular system. Results of this study showed that 
participants with BPPV+DM had higher postural sway measures compared to controls and the 
T2D group, which was particularly evident in the anteroposterior direction. Standing on foam 
with eyes closed and tandem stance conditions were the most challenging conditions for people 
with BPPV+DM.  
Besides causing symptoms of vertigo, BPPV is known to affect balance and functional 
mobility. However, BPPV can be effectively treated with canalith repositioning maneuvers. The 
effect of diabetes on symptom severity, mobility and balance and the response to treatment 
maneuvers in people with BPPV is unknown. In Chapter 5, we examined handicap due to 
dizziness, mobility, and balance in people between 40 to 80 years of age, in two groups, 34 
individuals with BPPV and 16 with BPPV+DM, before and after treatment with the canalith 
repositioning maneuver. To identify these deficits, all individuals completed the Dizziness 
Handicap Inventory (DHI), the Functional Gait Assessment (FGA) and postural sway tests, in 
quiet stance with altered visual and proprioceptive feedback. We found no differences between 
people with BPPV and those with BPPV+DM, on the DHI or FGA scores, at baseline and after 
symptom resolution. Significant differences were seen in postural sway between the groups at 
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baseline. However, after resolution of dizziness, there were no differences between the two 
groups on any postural sway measures. The number of treatment maneuvers required for 
resolution of vertigo did not differ between groups. People with BPPV with or without diabetes, 
made significant improvements in symptoms, mobility, and balance after their vertigo had 
resolved.  
 In summary, this body of work makes significant contributions to the existing literature 
examining the vestibular complications due to diabetes. Our central hypothesis was that diabetes 
would affect the otolith organs of the vestibular system, thereby increasing symptom severity, 
functional deficits, and balance sway, compared to people without T2D. Our findings were that 
although the prevalence of BPPV was higher in people with diabetes, hypertension was the 
complete mediator in the relationship between BPPV and T2D. People with BPPV+DM did not 
have increased otolith dysfunction, compared to those with BPPV or T2D only; however, 
postural sway was higher in people with BPPV+DM. The higher postural sway in people with 
BPPV+DM may be due to the presence of diabetic peripheral neuropathy; however, we did not 
analyze the effect of neuropathy on mobility and balance. There was no difference in the severity 
of symptoms and mobility deficits of people with BPPV + DM compared to people with BPPV 
only. Of importance, we found that people with BPPV+DM do respond well to treatment 
maneuvers with significant improvements in symptoms, mobility, and balance, and do not 
require additional treatment maneuvers, when compared to people with BPPV. Although our 
results did not fully support our central hypothesis, it provides valuable information. This body 
of work emphasizes the need for early diagnosis and prompt treatment of vestibular dysfunction 
in individuals with BPPV+DM.  Future studies examining falls in people with BPPV+DM 
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considering the influence of other diabetic complications, will help elucidate the relationship 
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Chapter 1 Preface 
 
 Diabetes causes many complications, including retinopathy and peripheral neuropathy, 
which are known to contribute to gait instability and falls. A less understood complication of 
diabetes is the effect on the vestibular system. In Chapter 1, we present evidence on the 
pathophysiology of diabetes-related complications and their influence on balance and falls, with 
specific attention to emerging evidence of vestibular dysfunction due to diabetes. This review of 
the literature has been published in the journal Physical Therapy as a “Perspectives article”. This 
type of manuscript is described by the journal as follows: “Perspectives contain new ideas, 
interpretations, and opinions and are intended to inform and advance practice in important 
ways. Perspectives are one of the most highly cited manuscript types, typically written by leaders 
in the field who set forth future direction.” We have made recommendations for examination as 
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1.1 Abstract  
 
Diabetes causes many complications, including retinopathy and peripheral neuropathy, 
which contribute to gait instability and falls. A less understood complication of diabetes is the 
effect on the vestibular system. The vestibular system contributes significantly to balance in 
static and dynamic conditions by providing spatially orienting information. It is noteworthy that 
both animal and clinical studies have reported that diabetes affects vestibular function. 
Pathophysiological changes in peripheral and central vestibular structures due to diabetes have 
been noted. Vestibular dysfunction is associated with impaired balance and a higher risk of falls. 
As the prevalence of diabetes increases, so does the potential for falls due to diabetic 
complications. The purpose of this perspective article is to present evidence on the 
pathophysiology of diabetes-related complications and their influence on balance and falls, with 
specific attention to emerging evidence of vestibular dysfunction due to diabetes. Understanding 
this relationship may be useful for screening (by physical therapists) for possible vestibular 
dysfunction in people with diabetes as well as for further developing and testing the efficacy of 











Diabetes Mellitus affects 29.1 million people in the United States- about 9.3% of the US 
population.
1
 Over the next 40 years, the prevalence of diabetes in the United States will increase 
from its current level of 1 in 10 to 1 in 3 because of the aging of the US population, longer life 
spans of adults with diabetes, and the increasing prevalence of obesity and physical inactivity.
2
 
The medical expenditures of people with diabetes are about 2.3 times higher than those of people 
without diabetes, with more than half of those expenditures being directly related to diabetes.
3
 




People with diabetes often develop multiorgan anatomic, structural and functional 
changes due to microvascular and macrovascular complications.
4
  Two common microvascular 
complications, peripheral neuropathy and retinopathy, are well established as contributors to 
increased postural sway and falls.
5, 6
 Although vestibular system dysfunction is not commonly 
recognized as a microvascular complication of diabetes, a recent epidemiological study reported 
that vestibular dysfunction was 70% higher in people with diabetes than in people matched for 
age and serving as controls.
7
 The prevalence of diabetes and vestibular dysfunction was higher in 
people with a longer duration of diabetes and with poor glucose control (i.e. higher serum 
glycated hemoglobin).
8
 In addition, animal and clinical studies reported structural and functional 
changes in the vestibular system due to diabetes.
9-11
 
If the vestibular system is adversely affected by diabetes, it will be important for physical 
therapists to consider the broad influence of diabetes on the risk of falls in older adults and other 
populations. Although most clinicians may be aware of the role of some diabetic complications 
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in increasing the risk of falls, the relationship between diabetes and vestibular dysfunction is not 
well known. The purpose of this perspective article is to present the pathophysiology of diabetic 
complications and their influence on balance and falls, with specific attention to emerging 
evidence of vestibular dysfunction due to diabetes. The clinical implications for physical 
therapists are discussed, as a comprehensive evaluation of the vestibular system may be 
necessary in people who have diabetes and balance impairment, and interventions that address all 
three sensory input systems (visual, vestibular and somatosensory), may be essential for reducing 
the risk of falls.  
1.3 Pathophysiology of Diabetic Complications 
 
Diabetes mellitus is a chronic metabolic condition characterized by elevated blood 
glucose levels resulting from the body’s inability to produce insulin, resistance to insulin action, 
or both.
12
 Chronic hyperglycemia plays a major role in the pathogenic mechanisms underlying 
microvascular (retinopathy, neuropathy and nephropathy) and macrovascular (peripheral 
vascular disease, cardiovascular disease and cerebrovascular disease) complications in diabetes.  
One mechanism of microvascular damage in diabetes is the result of chemical reactions 
between by-products of sugars and proteins, which forms irreversible cross-linked protein 
derivatives called advanced glycation end products.
13
 These derivatives affect the surrounding 
tissues causing thickening of collagen and endothelium. Other mechanisms contributing to 
microvascular disease include the abnormal activation of signaling cascades, such as the protein 
kinase C pathway, which increases vascular permeability; the polyol pathway, a mechanism by 
which sorbitol accumulation results in osmotic and oxidative stress damage to the endothelium.
14
 
The elevated production of  reactive oxygen species, by which oxygen-containing molecules 
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interact with other biomolecules and result in damage; and the abnormal stimulation of 
hemodynamic regulation systems, such as the renin-angiotensin system.
4
 
Damage to the peripheral nerves may occur through the irreversible changes to myelin 
protein caused by advanced glycation end products, which  results in segmental demyelination of 
the peripheral nerves.
13
 Damage to the neuronal microvascular leads to impaired nerve 
perfusion.
15
  Diabetic peripheral neuropathy affects up to two-thirds of  people with diabetes, and 
is characterized by pain, paresthesia and sensory loss.
16
 
Similar pathophysiological changes occur in the retinal vasculature in individuals with 
diabetes. In the United States, about 40% of people with type 2 diabetes and 86% with type 1 
diabetes develop retinopathy.
17
 Changes in the structure and cellular composition of the retinal 
vasculature are the hallmarks of early diabetic retinopathy. Damage to the endothelial cell lining 
causes an increase in vascular permeability, a breakdown of the inner blood–retinal barrier, and 
accumulation of extracellular fluid in the macula.
18
 Damage to pericytes, which are responsible 
for maintaining capillary tone, leads to altered retinal hemodynamics and abnormal 
autoregulation of retinal blood flow, which cause the development of micro aneurysms.
19
 
Thickening of the capillary basement membrane and retinal leukostasis leads to capillary 
occlusion and nonperfusion in the retinal microcirculation.
20
 These changes, in turn, stimulate 
pathologic neovascularization, which results in proliferative diabetic retinopathy and ultimately 
leads to retinal detachment and blindness.
21
 
People with diabetes, neuropathy, and retinopathy have significant physical limitations 
because of decreased proprioception and vision. Loss of light touch, visual acuity, contrast 
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1.4 Influence of Neuropathy and Retinopathy on falls 
 
The presence and severity of diabetic peripheral neuropathy (DPN) have been shown to 
increase postural instability.
22, 23
 People with DPN have a larger range of sway in the anterior-
posterior and medial-lateral directions and a higher sway speed than people matched for age and 
serving as controls.
22
 In quiet standing with eyes open, people with DPN have been shown to 
have 66% more sway than people who are of a similar age and healthy.
6
 The greatest decrease in 
postural stability in people with DPN has been observed with eyes closed; this finding reveals a 
reliance on vision to compensate for sensory deficits.
6
 In addition, decreased vibration sense and 
loss of pressure sensitivity are associated with recurrent falls.
24
 Because of decreased 
proprioceptive feedback during walking, older adults with diabetes walk slower and have greater 
stride variability; these factors increase the risk of falls.
25
 Similarly, strong associations are seen  
for diabetic retinopathy, the duration of diabetes and the risk of falls; with severe cortical 
cataracts being significantly associated with fractures.
26
  
Besides having a higher risk of falls, adults who are more than 70 years of age and have 
diabetes have been found to have a higher risk of sustaining more severe injuries after a fall.
27
 
Both elderly men and elderly women with diabetes, have a higher risk of fractures compared to 
adults without diabetes, despite similar bone mineral densities.
28, 29
 This compromised bone 
quality, which may be due to higher concentrations of advanced glycation end products in the 
bones because of diabetes,
30
 increases the risk of fractures by 64% in people with diabetes 
compared with people who are healthy.
29
  Pijpers et al
31
 found that in people who were more 
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than 65 years old and had diabetes, 30.6% fell recurrently, whereas 19.4% of people without 
diabetes fell recurrently; in that study, recurrent falls were defined as at least two falls within a 6-
month period.  
Although the diabetic complications of neuropathy and retinopathy clearly increase the 
risk of falls, other pathways may affect balance and gait in people with diabetes. For example, 
Chiles et al
32
 reported that after adjustment for age, sex, education, cognition, medications, and 
comorbidities (cardiovascular disease, hypertension, and kidney disease), people with diabetes 
had significantly decreased physical function (β = -0.99; p< .01), and decreased walking speed (β 
=-0.1 m/s; p<.01).
32
 Even after adjustment for impaired nerve function in the lower extremities 
(higher neuropathy scores), significant differences in physical function, balance and gait speed 
between people with diabetes and people without diabetes persisted.
32
 This evidence suggests 
that other pathways may affect balance and gait in people with diabetes.  
Because the vestibular system plays a major role in maintaining balance in both static and 
dynamic conditions, it is important to consider this as a potential mechanism by which balance 
and gait may be affected. Here we provide a brief summary of the anatomy and physiology of the 
vestibular system and an overview of studies showing the relationship between diabetes and 
vestibular dysfunction. 
1.5 Anatomy and Physiology of the Vestibular System 
 
The vestibular system makes significant contributions to both sensory and motor systems. 
As a sensory system, it provides the central nervous system with information regarding motion 
of the head as well as its position in space. The central nervous system uses this information 
along with information from the visual and somatosensory system to create an internal map of 
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the position and movement of the entire body in relation to the environment. The vestibular 
system contributes directly to motor output by producing compensatory eye movements to 
maintain a stable gaze and to coordinate postural control during movement.  
The peripheral sensory apparatus of the vestibular system comprises the semicircular 
canals and otolith organs. The three semicircular canals (anterior, posterior and horizontal) 
function as rate sensors by providing input regarding angular head acceleration.  The saccule and 
the utricle, which are the otolith organs, register forces related to linear acceleration as well as 
static tilt with respect to the gravitational axis.                                                                                                                                                                                                               
Specialized hair cells in each ampulla and otolith organ are the biological sensors that 
convert head position to neural firing. Type 1 hair cells are sensitive to rotations during large 
head accelerations, and type 2 hair cells are most effective during low frequency and small head 
accelerations. In addition, the maculae of the utricle and saccule contain otoconia, which are 
calcium carbonate crystals, embedded in a gelatinous matrix. The otoconia move in response to 




Information from the peripheral vestibular organs is processed in the central nervous 
system with input from the proprioceptive and visual systems. Motor output through the 
vestibular-ocular reflex (VOR) generates eye movements for gaze stability, and the 
vestibulospinal reflex generates muscle activity to maintain balance.  
The maintenance of balance depends on information provided by the somatosensory, 
visual and vestibular organs. These sensory systems provide information regarding body 
orientation within different frames of reference. Mirka and Black reported, “Vestibular input is 
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referenced to gravity, while somatosensory and visual inputs are referenced to the support 
surface and visual surrounds. Hence, the vestibular system provides orientation to earth vertical, 
while the other senses provide relative orientation references”.
34
 In people with impaired vision 
or somatosensory input, the vestibular system becomes very important for balance control.  
1.6 Evidence for Vestibular Dysfunction in Diabetes 
 
Morphological and physiological changes have been reported in the peripheral vestibular 
apparatus in animal models of diabetes. Myers and colleagues
11, 35
 found morphological and 
structural changes in the peripheral vestibular system in animals with experimentally induced 
diabetes. These animals had an overproduction of extracellular matrix as well as a higher 
incidence of lysosomes and lipid droplets in the connective tissue of the utricle and the saccule.
35
 
These findings were considered the consequences of metabolic stress. The accumulation of 
excess extracellular matrix leads to impaired diffusion of oxygen, nutrients and waste products. 
Hair cell degeneration, noted in these animals, was suggested to be the result of impaired 
diffusion. The level of type 1 hair cell degeneration was higher in the saccule, suggesting that the 
saccule may be more susceptible to pathology in diabetes.
35
 The vestibulocochlear nerve of rats 
with diabetes was observed to have large portions of disrupted myelin sheath lamellae as well as 
thinning of the myelin sheath and smaller axonal fiber diameters.
10, 36
 Perez et al
37
 observed 
physiological changes in the vestibular end organ due to diabetes in mice with diet-induced type 
2 diabetes. The latency of evoked potential responses was delayed, amplitudes were smaller, and 
thresholds were higher compared with those in control mice. Because short vestibular evoked 
potentials were recorded in response to linear and angular accelerations, damage due to diabetes 
was shown to affect function of the vestibular system.
37
 The Figure illustrates the potential 




Figure 1: Potential mechanisms contributing to vestibular dysfunction in diabetes based on 
animal studies. Figure created from information derived from Myers et al.10, 11, 35, 36 AGE= advanced 
glycation end products, ROS= reactive oxygen species.  
There is clinical evidence of the presence of vestibular dysfunction in people with 
diabetes. Clinical examinations with oculomotor tests, videonystagmography and caloric testing 
have shown that children and young adults who are 6 to 28 years of age and have type 1 diabetes 
have central as well as peripheral vestibular dysfunction. Abnormal responses include impaired 
optokinetic responses and eye tracking,
9, 38
 as well as reduced responses to caloric stimulation 
and positional nystagmus.
9, 39, 40
  The frequency of abnormal responses was higher in the 
participants with a longer duration of diabetes, those with retinopathy and neuropathy, and those 
who had frequent hypoglycemic incidents.
9, 40
 Despite the changes in central and peripheral 
structures, Biurrun et al reported no complaints of dizziness or imbalance
40
 and Gawron et al 
reported only 6.3% of the participants had complaints of dizziness and imbalance.
9
 In neither 
study was balance function in the participants examined. The minimal complaints of dizziness 
12 
 
could have been due to symmetrical impairment of function between the two inner ears.
37
 In 
people with type 1 diabetes, vestibular system dysfunction was seen more often than auditory 
dysfunction (60% versus 30%), indicating that metabolic disturbances may affect the 
homeostasis of the vestibular organ more quickly than the homeostasis of the cochlea.
39
  
Studies in people with type 2 diabetes have shown significant abnormalities in the phase 
of the vestibular ocular reflex (VOR) and the optokinetic reflex compared with those in people 
matched for age and serving as controls.
41
 Due to VOR abnormalities as well as optokinetic 
reflex abnormalities, people with diabetes could have blurring of vision during head 
movements.
41
 In adults with multiple chronic disorders, such as diabetes, hypertension, and 
dyslipidemia; cochlear and vestibular dysfunction was significantly prevalent,  particularly in 
people more than 60 years of age and having 2 or more comorbidities.
42
 Table 1 summarizes 
clinical studies examining vestibular dysfunction in people with type 1 and type 2 diabetes. 
Based on these studies, the strongest evidence presented is on VOR deficits, not balance 
problems- perhaps because direct assessment of the VOR is available during 
videonystagmography tests. Balance testing is more complex, and isolating the vestibular system 
is difficult because of proprioceptive feedback, as well as inherent compensatory strategies that 












Participants Evidence of Vestibular Dysfunction 






Type 1 DM 46 25.9 (8.9) 
 
 
21.8% of patients with DM had bilateral 
depressed caloric responses; oculomotor 
ENG tracings showed abnormal 
responses in 54.3% of participants with 
DM; abnormal responses were seen in 
participants with a longer duration of 
DM and with complications like 
retinopathy or nephropathy  





Type 1 DM 95 
 
 
15.5 (5.1) Impaired optokinetic responses and 
significant increases in spontaneous and 
positional nystagmus were seen in 
participants with severe hypoglycemic 
incidents, a longer duration of  DM and 
uncontrolled diabetes 





Type 1 DM 
 
18 62.7 (21.1) Gaze holding in darkness was worse for 
participants with DM than for controls;  
VOR gain was similar in the groups; 
however, phase velocity was decreased 
in participants with type 1 diabetes; 
OKR slow-phase velocity was decreased 
in both groups with DM, and postural 
sway was increased in both groups with 
DM 
Type 2 DM 
 
23 65.4 (10.5) 
Control 
 








176        57 (13) The prevalence of DM in participants 
with BPPV was significant (p<.001); 
equilibrium scores on condition 5 of the 
SOT were significantly lower in 
participants with BPPV and DM than in 





Type 1 DM 30 25.7 Caloric test abnormalities were seen in 
60% of participants; 40% had 
hyporeflexia, and 20% had 
hyperreflexia; spontaneous nystagmus, 
positional nystagmus, and optokinetic 





Adults >40 y 
old 
4,743  The modified Romberg Test of Standing 
Balance on Firm and Compliant surfaces 
was used to determine vestibular 
dysfunction; odds of vestibular 
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dysfunction were 70% higher in people 
with DM; the risk of falls in people with 
vestibular dysfunction and complaints of 
dizziness was increased 12-fold 
Kim et al
44
 Type 2 DM 35 51.1 (15.5) 19 participants with DPN and 
complaints of vertigo received vestibular 
testing, which included a clinical 
examination for spontaneous and gaze-  
evoked nystagmus, positional testing, 
VNG and caloric tests; 11 participants 
(57.9%) had vestibular dysfunction, on 










385 62 (12.9) 40% of the study population had 
complaints of dizziness and received 
vestibular testing, spontaneous 
nystagmus was seen in 2.8% of the 
population; abnormal caloric responses 
were seen unilaterally in 73.4% of the 








1,092 72.9 (6.14) The number of recurrences of BPPV was 
related to the number of comorbidities; 
the combination of hypertension, 
diabetes, osteoarthritis, and osteoporosis 
increased the risk of recurrence 6.48 
times. 
a 
DM=diabetes mellitus, ENG=electronystagmography, VOR=vestibular-ocular reflex, OKR= optokinetic 
reflex, BPPV=benign paroxysmal positional vertigo, SOT=sensory organization test, DPN=diabetic 
peripheral neuropathy, VNG=videonystagmography. 
 
The odds of developing vestibular dysfunction are 70% higher in adults with diabetes 
than in those without diabetes.
7
 In a large epidemiological study, Agrawal et al
7
 examined data 
from adults 40 years of age and older (N= 5,086), by using the modified Romberg Test of 
Standing Balance. Participants had to stand unassisted for 30 seconds in each of the following 
four positions: on firm ground with eyes open, on firm ground with eyes closed, on a foam 
surface with eyes open, and on a foam surface with eyes closed. Fifty-four percent of the 
participants with diabetes were identified as having vestibular dysfunction because they had to 
take a step or open their eyes when standing on foam with eyes closed. The risk of falls was 12 
15 
 
times higher in the participants who had vestibular dysfunction and complaints of dizziness than 
in those without either complaint.
7
 Of interest, the participants with vestibular dysfunction but 
without complaints of dizziness also had a significantly higher risk of falls.
7
 The prevalence of 
vestibular dysfunction was directly related to the duration of diabetes. Participants with a history 
of diabetes of up to 5 years had a 41% prevalence of vestibular dysfunction, whereas a 61% 
prevalence of vestibular dysfunction was seen both in participants with a history of diabetes of 6 
to 10 years and in those with a history of diabetes of more than 10 years. Higher serum glycated 
hemoglobin levels (≥ 7.0 U) increased the odds of vestibular dysfunction by 60%.
8
 The 
prevalence of vestibular dysfunction was higher in participants with other diabetes-related 




The limitation of these studies
7, 8
 was that the assessment of vestibular dysfunction was 
done using the modified Romberg Test of Standing Balance. There was no direct assessment of 
the vestibular system using calorics or evoked potential studies. The modified Romberg Test of 
Standing Balance has weak correlations with the Dizziness Handicap Inventory (r=0.26). 
However, when compared with caloric or vestibular evoked potential testing, the modified 
Romberg Test of Standing Balance has a sensitivity of 55% and a specificity of 65% for the 
detection of peripheral vestibular dysfunction, making it a poor screening tool for vestibular 
dysfunction.
46
 Future studies of the relationship between direct assessment of the peripheral 
vestibular organs and balance and function in adults with diabetes are essential. 
Degerman et al
47
 examined the human saccule and identified the insulin receptor, insulin 
receptor substrate1, protein kinase B, and insulin- sensitive glucose transporter (GLUT4) in the 
sensory epithelium of the human saccule. These signaling mechanisms maintain ion and water 
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homeostasis in the saccule, and are important for oto-protection and neuronal survival. Chronic 
hyperglycemia and insulin resistance can affect these signaling pathways,
48
 resulting in impaired 
inner ear function.   
One particularly common vestibular condition, benign paroxysmal positional vertigo 
(BPPV), has been studied in adults with diabetes. In a histopathology study, Yoda et al
49
 
examined 28 temporal bones of people with type 1 diabetes and compared them with the 
temporal bones of 56 people, who were matched for age and healthy (controls). None of the 
individuals with type 1 diabetes had a documented medical history of vestibular or balance 
problems. Each temporal bone was sectioned at a thickness of 20µm, stained with hematoxylin 
and eosin, and studied under light microscopy. The cupulae were observed by light microscopy 
at a magnification of X400. A significantly higher prevalence of deposits of otoconia were seen 
in people with type 1 diabetes than in the controls, both  in the posterior and lateral semicircular 
canals, as well as attached to the cupula.
49
 Cohen et al
43
 reported a significantly higher 
prevalence of diabetes in people with BPPV. In adults who were 65 to 74 years of age, 20% of 
those with BPPV had diabetes; in comparison, 9.2% of people in the general population have 
diabetes.  In addition, comorbidities like diabetes and hypertension have been shown to increase 
the recurrence rate of BPPV.
50
 The combination of hypertension, diabetes, and osteoarthritis 
increases the risk of recurrence of BPPV 4.55 times.
50
 Once diagnosed, BPPV is effectively 
treated by appropriate repositioning maneuvers.
51
 These results suggest that vestibular 
dysfunction could be considered an underreported complication of diabetes. Vestibular 
dysfunction independently increases the risk of falls, and may be considered an independent 





Based on the literature presented, there appears to be a complex relationship between 
diabetes and vestibular dysfunction in people with both type 1 and type 2 diabetes. Damage to 
the inner ear may cause individuals with diabetes to have impaired gaze stability. In addition, 
there may be decreased sensory feedback from the peripheral vestibular organs due to 
hypofunction of the otolith organs and semi-circular canals. Hence, the high risk of postural 
instability and falls may be further increased because of vestibular dysfunction. The prevalence 
of BPPV also may be increased in people with diabetes. This information may be important to 
physical therapists that treat people with diabetes.    
1.7 Clinical Implications for Examination and Treatment of People with Diabetes  
  
Physical activity and exercise are essential components for managing diabetes and 
preventing complications,
52, 53
 and clinical guidelines have been published to provide 
recommendations for starting and advancing an exercise program for people with type 2 
diabetes.
54
 However, the vestibular system is not included in these guidelines because vestibular 
dysfunction is not yet a widely recognized complication of diabetes. Here we present 
recommendations for physical therapy examinations and interventions that include an awareness 
of the possible role of vestibular dysfunction in people with type 2 diabetes.  
1.7.1. Recommendations for Examination  
For a clear understanding of the impact of diabetes on the vestibular system, a 
comprehensive examination of the vestibular system is necessary. The use of appropriate 
outcome measures can help identify deficits, provide direction for treatment, and improve 
outcomes for patients. Function and participation in daily activities can be assessed using 
standardized questionnaires.  
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The Dizziness Handicap Inventory is a measure of self-reported activity limitation and 
participation restriction due to either dizziness or unsteadiness.
55
 It is a 25-item questionnaire 
with three subscales: functional, emotional and physical. The maximum score is 100 points (32 
for the functional dimension, 40 points for the emotional dimension, and 28 points for the 
physical dimension). Higher scores indicate greater levels of self-perceived disability. People 
with scores of more than 60 points on the Dizziness Handicap Inventory have impaired 
functional mobility and a higher risk of falls.
56
  
The Activities-specific Balance Confidence Scale is a 16-item measure of self-efficacy 
on a 10-point ordinal scale; people rate their confidence in maintaining their balance during 
various activities of daily living. Scores range from 0-100 points, where zero indicates no 
confidence. Scores of more than 80 points indicate high functioning, observed in physically 
active older adults;
57
 scores of less than or equal to 67 points indicate an increased risk of falls.
58
 
The Activities-specific Balance Confidence Scale may be a useful tool for assessing people’s 
level of confidence as a treatment plan is developed. Symptom severity can be assessed with a 
visual analog scale and the Vertigo Symptoms Scale, both of which can be used to monitor 
people’s progress during the course of treatment.
59
 
Because damage to the vestibular system is associated with increased postural sway and 
balance impairment,
60, 61
 it is necessary to examine static balance as well as balance during 
dynamic activities. The Modified Clinical Test of Sensory Integration of Balance is a useful test 
that can be performed easily in the clinic setting to challenge the vestibular system while altering 
proprioceptive and visual feedback.
62
 The Sharpened Romberg Test is particularly valuable in 
the clinic setting because people with type 2 diabetes have been shown to have higher medial-
lateral sway.
23
 In addition, we can assess the risk of falls with reliable tests that are validated in 
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individuals with DPN. Using modified cutoff scores of greater than or equal to 10.7 seconds on 
the Timed “Up & Go” Test, scores of less than or equal to 22 on the Dynamic Gait Index, and 
scores of less than or equal to 52 on the Berg Balance Scale, fallers may be accurately identified. 
Based on these cut-off scores, Jernigan et al identified the Timed “Up & GO” Test as most 
accurate to predict fallers; the Dynamic Gait Index  and Berg Balance Scale were less accurate.
63
 
Even though the Functional Gait Assessment is not specifically validated in people with diabetes, 
it may be useful for identifying the risk of falls. People with vestibular dysfunction and scores 




Oculomotor and gaze-holding deficits are seen in people with diabetes; hence, assessment 
of the vestibular system should include gaze stability testing. The Dynamic Visual Acuity test 
provides information to clinicians regarding the degradation of visual acuity with rapid head 
movements. The patient reads a wall eye chart with the head stationary, followed by head 
oscillations at 2 Hz. A loss of the ability to read 3 or 4 lines on the chart suggests decreased gaze 
stability.
65
 Making a diagnosis of BPPV in older adults with dizziness, multiple comorbidities, 
and coexisting cardiovascular disease is difficult, resulting in delayed interventions.
66
 Hence, 
performing the Dix-Hallpike test to assess anterior and posterior canal BPPV, and the Roll test to 
assess the horizontal canal in patients complaining of dizziness or vertigo may help identify the 
presence of BPPV.
67
 It is necessary to examine patients for diabetic complications such as 
peripheral neuropathy and lower extremity pain. The Michigan Neuropathy Screening 
Instrument can be easily completed in the clinic setting; scores of greater than or equal to two on 
the physical examination section indicate the presence of neuropathy.
68, 69
 Pain due to neuropathy 
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can be assessed using the Brief Pain Inventory for DPN, a scale validated for people with DPN; 
it assesses pain severity as well as how the pain may affect various aspects of daily life.
70
   
1.7.2. Suggestions for Interventions 
Gaze stability exercises are effective in reducing the risk of falls in adults with vestibular 
dysfunction.
71
 However, the role of gaze stability exercises in people with type 2 diabetes has not 
been explored. In people with diabetes, deficits in the VOR and the optokinetic reflex may make 
maintaining a stable gaze during dynamic activities difficult;
41
 hence, we recommend the use of 
gaze stability exercises for maintaining a stable gaze and reducing the risk of falls in this 
population. Recommended gaze stability exercises include X1 viewing, X2 viewing, or both.
65
  
Although studies have shown that BPPV may be more prevalent as well as recurrent in 
adults with diabetes,
43, 50
 no studies have examined the response to repositioning maneuvers in 
patients with type 2 diabetes and concurrent BPPV. In patients with BPPV, providing 




The roles of aerobic exercise, resistance exercise, and a combination of these exercises 
are well established; these exercises have been shown to improve glycemic control, overall 
physical function, balance, and gait speed in people will diabetes.
32, 53, 73-75
 Balance training has 
been shown to improve postural control and clinical measures of balance; however, the intensity 
and duration of balance training as well as presence of diabetic complications may affect 
outcomes. Kruse et al
76
 found no improvement in balance after a 12-month training program that 
included balance exercises; however, Allet et al
77
 reported significant improvement in balance 
with similar exercises. The two studies differed in the frequency and mode of delivery of the 
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training program as well as the severity of neuropathy. For patients with diagnosed DPN, Kruse 
et al
76
 prescribed balance training with a physical therapist once a week for 11 weeks.  After this 
initial training period, subjects received regular phone calls encouraging them to continue the 
exercise program.
76
 Allet et al
77
 prescribed training 2 times per week for 12 weeks, for 60 
minutes per session, in a physical therapy clinic; however, their patients had minimal 
neuropathy. Table 2 summarizes a few studies that used balance-training programs to improve 
balance and function in people with type 2 diabetes.  
Beside weakness and imbalance, many factors contribute to falls in people with type 2 
diabetes; these include glycemic control, fatigue, executive function, inappropriate footwear, 
polypharmacy, proprioceptive loss, and retinopathy.
32, 78-80
 The American Diabetes Association 




Because of somatosensory and visual disturbances, adults with diabetes are limited in 
their ability to reweigh sensory information. Evaluation for an assistive device may be necessary, 
particularly in people who are not confident with walking outdoors or are limited in participation 
due to dizziness. The added stability of an assistive device may encourage older adults with 







Table 2: Table 2: Summary of balance training interventions in people with type 2 diabetes 
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IG: intervention group, CG: control group, FRT: Functional Reach Test, ABC: Activities Specific 
Balance Confidence Scale, BBS: Berg Balance Scale, FES: Falls Efficacy Scale, POMA: Performance- 
Oriented mobility assessment, PPA: Physiological profile assessment, SLS: Single leg stance, EO: eyes 
open, EC: eyes closed, OSI: overall stability index, APSI: Anterior-posterior stability index, MLSI: 
Medio-lateral stability index, WB: weight bearing, NWB: non- weight bearing. 
 
1.8 Conclusion  
 
The relationship between diabetes, vestibular function and the risk of falls is complex. 
People with diabetes have many deficits, including neuropathy, retinopathy, and polypharmacy, 
all of which compromise their activity and daily functional status. Vestibular dysfunction is 
another possible complication of diabetes and may increase the risk of falls. Understanding this 
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relationship, identifying and treating BPPV, and working toward integrating all systems-- visual, 
vestibular and somatosensory-- to improve balance may be ways in which physical therapists can 


















Chapter 2 Preface 
 
Chapter 1 provides an overview of what is currently known about the effect of type 2 
diabetes on the vestibular system in general. It also gives insight into the potential impact 
diabetes may have on quality of life, balance and mobility. However, vestibular dysfunction is a 
very broad term, encompassing many vestibular disorders. In order to develop specific aims for 
the project, we designed a retrospective study to identify whether there was a difference in 
prevalence between different vestibular conditions in people with diabetes. One vestibular 
condition, benign paroxysmal positional vertigo (BPPV), has been reported in higher frequency 
in people with diabetes; however, the relationship between diabetes and BPPV, in the presence 
of known contributors like age, gender and hypertension, is not clear. 
Results of our study confirmed that BPPV was present in higher frequency in people with 
type 2 diabetes, compared to the other conditions. As we examined the different predictors of 
BPPV, we found hypertension to be a significant predictor that mediated the relationship 
between diabetes and BPPV. Based on the results of this study, we developed the aims for this 










Retrospective Data suggests that the Higher Prevalence of Benign Paroxysmal 
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Objective: Benign Paroxysmal Positional Vertigo (BPPV) has been linked to comorbidities like 
diabetes and hypertension. However, the relationship between type 2 diabetes (DM) and BPPV is 
unclear. The purpose of this retrospective study was to examine the relationship between DM 
and BPPV in the presence of known contributors like age, gender and hypertension.  
Methods: A retrospective review of the records of 3933 individuals was categorized by the 
specific vestibular diagnosis and for the presence of type 2 DM and hypertension. As the 
prevalence of BPPV was higher in people with type 2 DM compared to those without DM, 
multivariable logistic regressions were used to identify variables predictive of BPPV. The 
relationship between type 2 DM, hypertension and BPPV was analyzed using mediation analysis.  
Results: BPPV was seen in 46% of individuals with type 2 DM, compared to 37% of individuals 
without DM (p<0.001). Forty two percent of the association between type 2 DM and BPPV was 
mediated by hypertension, and supported hypertension as a complete mediator in the relationship 
between type 2 DM and BPPV. 
Conclusions: Hypertension may provide the mediating pathway by which diabetes affects the 
vestibular system. Individuals with complaints of dizziness, with comorbidities including 








Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder, affecting 
about 1.6% of the adult population per year.
88
 The main symptom of BPPV is vertigo which is 
position dependent and transient.
67
 Patients typically develop vertigo when looking overhead, 
getting in or out of bed, and bending. When symptomatic, 86% of individuals with BPPV have 
been shown to restrict daily activities, while 18% avoided leaving their homes.
88
 Fortunately, 




Known factors associated with a higher prevalence of BPPV include age, female sex, 
history of head trauma, other inner ear disease including Meniere’s disease and vestibular 
neuritis, osteoporosis, and migraines.
88, 91-94
 Vasospasm of the labyrinthine arteries may cause 
detachment of otoconia from the macula, seen in conditions like migraine.
95
 BPPV is associated 
with hypertension and hyperlipidemia, due to possible vascular damage to the inner ear, and is a 
known sequel of labyrinthine ischemia that precipitates detachment of the otoconia.
42, 88
 The 
relationship between diabetes (DM) and BPPV is not well understood. However, in people with 
type 2 DM, the risk of diabetic complications have been shown to increase significantly when 
systolic blood pressure is high.
96
 The prevalence of hypertension is 40-60% higher in people 
with type 2 DM between 45-70 years of age, compared to the nondiabetic population.
97
 Cohen et 
al
43
 reported DM as being unusually prevalent in patients with BPPV, and comorbidities like 
hypertension and diabetes, have been shown to significantly increase the recurrence rate of 
BPPV,
45
 however Warninghoff et al
98
 did not detect an increased prevalence of DM or 
hypertension in individuals with vertigo. By the year 2030, the prevalence of DM globally is 
estimated to rise to 366 million people 
99





 It is necessary to understand the relationship between BPPV, hypertension 
and type 2 DM because making a diagnosis of BPPV in older adults, with multiple comorbidities 
is difficult.
101
 In fact, the prevalence of unrecognized BPPV in elderly people with multiple 
chronic diseases is as high as 9%,
66
 which could potentially delay treatment maneuvers.  
This study was a retrospective, observational study that investigated the interaction 
between type 2 DM and vestibular disorders as they naturally occur within individuals managing 
chronic disease through their adult lifespan. Because animal research has shown morphological 
changes in the saccule of diabetic rats, 
35
 and clinical research has shown a higher prevalence of 
BPPV in type 1 and type 2 DM,
43, 49
 our hypothesis was that in people with type 2 DM, the 
prevalence of BPPV may be higher. We examined the role of known contributing factors such as 
age, gender, and hypertension; as well as the potential mediating relationship between type 2 
DM, hypertension, and BPPV. 
2.3 Materials and Methods 
  
Following Institutional Review Board approval from the University of Kansas Medical 
Center (KUMC), data was collected using the Healthcare Enterprise Repository for Ontological 
Narration (HERON), which is a medical records system. HERON is built upon the i2b2 
integrated clinical data repository software.
102
 This database integrates data from electronic 
medical records, as well as the billing system to provide de-identified medical data pieces, 
preserving patient privacy.
103
 Using a query search in Heron, data for this study was extracted 
from the University of Kansas Hospital inpatient and emergency room records as well as from 
area outpatient clinics affiliated with KUMC, that use the electronic medical record system. 
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Data was obtained on individuals 18 years and older. Our population of interest was 
patients with a vestibular diagnosis for their complaints of dizziness (ICD9 code 386.1- 386.5) 
between October 2006 and December 2012. We collected data on age at the time of the 
vestibular diagnosis, sex, race, smoking history, and specific vestibular diagnosis. The presence 
or absence of type 2 diabetes and hypertension were collected within the data query, making sure 
to identify the date of first diagnosis of diabetes and hypertension. This was used to determine if 
diabetes and hypertension were present before or after the vestibular diagnosis, thus helping us 
classify the cases as having type 2 diabetes and hypertension or not. Our query included a 
population inclusive of a range of vestibular diseases with and without diabetes.  We excluded 
individuals with type 1 DM from the analysis.  
2.4 Statistical Analysis  
 
Chi-square tests were used to compare the frequency of specific vestibular diagnoses in 
people with and without type 2 DM. Descriptive statistics describe the presence of comorbidities 
in individuals with BPPV.  
Univariate logistic regression was used to identify the variables with significant 
relationship to BPPV. Variables with significant relationship to BPPV were included in a 
multivariable logistic regression analysis. Factors included in the model were age, sex, race, 
presence of hypertension and diabetes, which were entered in a backward stepwise regression 
model.  
We tested the mediating effect of hypertension on the relationship between type 2 DM 
and BPPV using multiple regression analyses. According to Baron and Kenney,
104
 mediation is 
demonstrated when the following relationships are observed: 1) the main independent variable 
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(type 2 DM) is significantly associated with the main dependent variable (BPPV), 2) the 
independent variable (type 2 DM) is significantly associated with the mediator variable 
(hypertension), 3) the mediator variable (hypertension) is significantly associated with the 
dependent variable (BPPV) when the independent variable (type 2 DM) is controlled. All 
analyses were conducted at the 0.05 level of significance a priori, using SPSS 20.0 for Windows 
(Chicago, IL).  
2.5 Results 
 
The HERON search results identified 3933 electronic medical records, of which, 12 
individuals had type 1 DM and were excluded from the analysis. There were nine vertiginous 
conditions frequently diagnosed, BPPV was the most common among people with and without 
type 2 DM (n=1518). BPPV was present in 46% of the sample who had concurrent DM (n=322), 
and in 37% of individuals who did not have concurrent DM (n=1196), this proportion was 
significantly higher than expected (p< 0.001) (Table 1). 
Table 1: Frequency of vertiginous diagnoses in people with and without type 2 DM 
 With Type 2 DM 
(n= 699) 
 



































Chi-square tests were used to examine differences in frequency between groups. * Significant difference 
between groups is based on p<0.05 DM=diabetes 
 
2.5.1 Descriptive Statistics of Individuals with BPPV: 
 The mean age of people with BPPV was 59 ± 15.8 years, while those with BPPV and 
type 2 DM was 66 ± 12.8 years. The female to male proportion in both groups was 68% female 
and 32% male. The frequency of hypertension and type 2 DM in people with BPPV was 
stratified by age group (Table 2). Two percent of patients (n=79) had BPPV and coexisting 
Meniere’s disease, 1% (n=45) had BPPV and a diagnosis of central vertigo, 0.6% (n=23) had 
BPPV and vestibular neuronitis, while 0.9% (n=36) had BPPV and a diagnosis of labyrinthitis. 
Table 2: Presence of hypertension and type 2 diabetes in people with BPPV (n=1518) 
People with BPPV  Hypertension: yes Hypertension: no 
Between 18- 40 years   
Diabetes: yes (n=10) 50%  (n=5) 50% (n=5) 
Diabetes: no (n=161) 11.2%  (n=18) 88.8% (n=143) 
Between 41- 65 years   
Diabetes: yes ( n=131) 80.2% (n=105) 19.8% (n=26) 
Diabetes: no (n=611) 30.6% (n=187) 69.4% (n=424) 
People > 65 years   
Diabetes: yes (n= 181) 90.1% (n=163) 9.9% (n=18) 
Diabetes: no (n= 424) 56.6% (n= 240) 43.4% (n= 184) 
BPPV=benign paroxysmal positional vertigo 
2.5.2 Analysis of Variables with Logistic Regression: 











Variables with a significant relationship to BPPV included age (independent sample t-
test, p<0.001), sex (chi square test, p=0.008), race (chi square test, p< 0.001), diabetes (chi 
square test, p<0.001) and hypertension (chi square test, p<0.001). Using a backward stepwise 
regression model, we found that age, sex, race and hypertension were the significant variables 
predictive of BPPV (Table 3).  
Table 3: Logistic linear regression model showing the variables predictive of and odds of 
developing benign paroxysmal positional vertigo  
95% CI= 95% confidence interval, significant p-value is <0.05 
The prevalence of BPPV was higher with increasing age and female gender. African-
American were 1.3 times more likely to present with BPPV, while Asians were 2.6 times more 
likely to present with BPPV, compared to their Caucasian counterparts. In people with 
hypertension, the frequency of BPPV was 1.7 times higher; diabetes did not influence the 
presence of BPPV in the multivariate analysis.  
Factors B Odds Ratio (95% CI) p-value 
Age (by decade) 0.01 1.10(1.06-1.15) 0.01 
Gender (female- reference) n= 2603 0.18 1.19(1.04-1.38) 0.01 
Race (White-reference) n= 2977 
Race (African American) n= 396 
Race (Hispanic) n= 13 
Race (Asian) n= 50 




















Figure 1: Hypertension is the mediator of the association between type 2 diabetes and 
benign paroxysmal positional vertigo. a= coefficient relating type 2 DM to hypertension, 
b=coefficient relating hypertension to BPPV, c= coefficient relating type 2 DM to BPPV, 
c’= coefficient relating type 2 DM to BPPV while adjusting for hypertension. 
Figure 1 illustrates the mediation effect and shows that hypertension mediated the 
association between type 2 DM and BPPV. The effect can be expressed as (0.39 x 0.15)/ [(0.39 x 
0.15) + 0.08] = 42.2%. In the presence of hypertension, the association between type 2 DM and 
BPPV is no longer significant, showing that hypertension is a complete mediator in the 
relationship between type 2 DM and BPPV. Hypertension was present in 86.8% of individuals 
with type 2 DM, compared to 37.2% with BPPV without type 2 DM. This relationship between 
type 2 DM and hypertension was present in all age groups.  
2.6 Discussion 
 
Results of this study show that hypertension was a strong predictor of BPPV and 
completely mediated the effect of diabetes on BPPV. The close association between type 2 DM 





overall prevalence of hypertension in people with DM is as high as 71%, of which only 12% 
have their hypertension controlled (<130/85 mm of Hg).
106
 Microvascular and macrovascular 
complications are significantly higher in people with type 2 DM and hypertension.
107
 Some  
mechanisms by which hyperglycemia increases vascular resistance is by inhibiting nitric-oxide 
related vasodilation, by disrupting nitric oxide signaling as well as by forming reactive oxygen 
species (ROS). Formation of advanced glycation end products through the polyol pathway 
increases formation of ROS, 
108
 which further depletes nitric oxide. In addition, activation of the 
protein kinase pathway leads to cell proliferation, leading to increased stiffness of arterial 
walls.
109
 These mechanisms are responsible for vasoconstriction of small arterioles leading to 
tissue ischemia. The vascular effects of hypertension and diabetes may be possible mechanisms 
leading to tissue hypoxia and cochleovestibular degeneration.
110, 111
 Results of our study are in 
agreement with other studies of hypertension in vestibular dysfunction.
42, 88
 Chavez-Delgado et 
al
42
 report that hypertension, type 2 DM and dyslipidemia resulted in the highest percentage of 
cochlear and vestibular dysfunction, with hypertension present in 74% of their study population 
(n=385). Besides microvascular damage, macrovascular damage is seen in people with diabetes 
and hypertension. Arteriosclerotic changes were seen in the carotid arteries of 71% of people 
with BPPV compared to 43% of people with other vestibular disorders,
112
 while stenosis or 
occlusion of the vertebrobasilar artery was seen in 21% of people with BPPV, compared to 6.8% 
of people without BPPV.
113
 Elderly people (mean age 57.36±15.44 years) with BPPV and 
comorbidities like hypertension and diabetes have a higher risk of ischemic stroke (4.5% 
compared to 2.9% without BPPV).
114
  
The effect of diabetes on the peripheral vestibular organs has been examined in animal 





 with type 1 hair cell degeneration seen, particularly in the saccule. These 
changes were considered signs of metabolic stress due to hyperglycemia,
35
 however the impact 
of diabetes on the dislodgement of otoconia has not been reported. However, in a 
histopathological study examining the temporal bones of patients with type 1 diabetes, Yoda et 
al. noted a higher prevalence of otoconia deposits in the semicircular canals as well as adhered to 
the cupula, compared to age matched controls.
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We examined other known factors associated with a higher prevalence of BPPV like age, 
gender and race. Aging has been shown to cause changes in the protein and gelatinous matrix of 
the otolith membrane, as well as weakening of the linking filaments among otoconia with 
fragmentation of the otoconia.
115
 This results in displacement of the otoconia into the 
semicircular canals. Our study showed that the presence of BPPV increased by 10% for every 
advancing decade of life. Twice as many females were diagnosed with BPPV as compared to 
males. This is aligned with current literature showing that there is a marked female 
preponderance in BPPV;
88
 this female preponderance may be linked, among other factors, to 
migraines or hormonal factors.
92-94
 Estrogen deficiency is known to disturb the internal structure 
of the otoconia and their interconnection, and attachment to the matrix.
94, 116
 Regarding race, we 
found that African-Americans were more likely to have BPPV compared to Caucasians. This 
finding could be because the age adjusted prevalence of diagnosed diabetes is higher in African-
American individuals compared to Caucasians, and is highest in general, in African-American 
women.
117
 Of interest, our study showed that BPPV was present in higher frequency in the Asian 
community. Previous research has shown a higher prevalence of DM and its complications in the 
Asian population.
118
 In our study, the mean age in the Asian population was younger (56 ± 14 
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years) than the mean for the overall population, more commonly female (72%) and comorbidities 
included hypertension and diabetes 37.9% and 20.7% of the time respectively.  
Another result of this study was that unspecified peripheral vertigo and other disorders of 
the labyrinth, conditions whose etiology is unclear, was seen more commonly in people without 
type 2 DM. It is possible that in people with comorbidities like diabetes and hypertension, 
referrals to specialists are higher, which may not be the case for people without DM. Referrals to 
specialists in tertiary care centers usually result in revised and specific diagnoses.
119
 Thirty-four 
percent of our cases had a diagnosis of Meniere’s disease. This may be because KUMC is a 
tertiary care center with specialists in the field of neuro-otology, resulting in a higher referral rate 
to this center. These are interesting observations that require further investigation. 
Results of our study suggest a multifactorial and interrelated risk that may influence the 
presence of BPPV in people with DM. Being aware of the relationship between BPPV, type 2 
DM and hypertension may benefit clinicians. Since hypertension, diabetes and BPPV can 
independently cause dizziness, it is important for the clinician to examine all potential causes of 
dizziness carefully. Asking specific questions, to determine if BPPV could be a source of the 




One limitation of this study is the retrospective nature of data collection. Every effort was 
made to exclude type 1 DM and ensure that the diagnosis of diabetes and hypertension predated 
the vestibular diagnosis. We found that the prevalence of BPPV was 9% higher in those with 
type 2 DM compared to those without DM. Although this difference was statistically significant, 
we cannot establish if this is a clinically meaningful difference. This was an observational study 
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hence the cause/ effect relationship between diabetes and BPPV cannot be established. In this 
study, indicators of DM severity (e.g. HbA1c levels, fasting glucose) were not consistently 
available. Future studies examining relationships between DM, glycemic control, and severity of 
vertiginous symptoms will assist clinicians in the management of these patients.  
2.7 Conclusion 
 
In summary, this study shows that hypertension is the mediating factor contributing to the 
increased prevalence of BPPV in individuals with type 2 DM. Hypertension may cause vascular 
damage to the macula of the utricle and saccule, resulting in dislodgement of the otoliths. 
Improved understanding about the role of hypertension and DM as risk factors for the presence 
of BPPV can help generate new pathophysiological hypotheses that may ultimately help to 













As illustrated in the first two chapters, diabetes affects the vestibular system and the 
prevalence of benign paroxysmal positional vertigo is higher is people with diabetes. BPPV 
results when otoconia fragments dislodge from the saccule and utricle, and fall into the 
semicircular canals, causing movement of the endolymph, after head movements have ceased. 
Both disease processes independently increase postural sway and risk of falls, while limiting 
mobility and daily function. The prevalence of BPPV increases with age, hence as the population 
ages the coexistence of both disease processes will increase. Fortunately, because of effective 
repositioning maneuvers, BPPV is very successfully treated. The effect of diabetes on the 
saccule and utricle, in people with BPPV, is not known. The severity of symptoms as well as 
mobility and balance deficits due to the presence of both disease processes needs further 
examination. The prognosis of patients with BPPV and diabetes treated with repositioning 
maneuvers is not clear and the recovery of function after treatment is not clear. The main 
objective of this body of work was to examine differences in symptom severity, functional 
mobility and balance in people with BPPV and diabetes compared to people with BPPV only. We 
examined the efficacy of treatment and change in function after repositioning treatment 
maneuvers in both groups. The specific aims proposed for this study are as follows: 
Specific Aim 1: To determine if there are differences in symptom severity, mobility and balance 
in people with posterior canal BPPV and diabetes compared to people with BPPV only. 
People with diabetes suffer from diabetic complications like neuropathy and retinopathy, which 
impair balance and mobility. In addition, there may be a possible direct effect of diabetes on the 
otolith organs of the inner ear. We hypothesized that people with both BPPV and diabetes would 
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have higher deficits on the Dizziness Handicap Inventory, which is a self-report measure relating 
to daily activities (Hypothesis 1). They would have greater impairment in functional mobility 
measured by the Functional Gait Assessment (Hypothesis 2), and they would have increased 
postural sway in conditions that challenge the vestibular system (Hypothesis 3), when compared 
to people with BPPV only. 
Specific Aim 2: To examine the effect of type 2 diabetes on the otolith organs, namely the 
saccule and the utricle of the inner ear.    
Vestibular evoked myogenic potential tests have shown that BPPV and diabetes independently 
affect the responses of the saccule and utricle. The combined effect of BPPV and diabetes on the 
saccule and utricle is not clear. We hypothesized that the latency, amplitude, and threshold of the 
cVEMP will be affected reflecting impairment in saccule function (Hypothesis 4), and the latency 
and amplitude of the oVEMP will be affected showing impairment in utricle function (Hypothesis 
5) in people with BPPV and diabetes compared to people with BPPV only, T2D only and 
controls. 
Specific Aim 3: Identify differences in efficacy of treatment and recovery of function after 
resolution of vertigo in people with BPPV and diabetes compared to people with BPPV only.  
T2D has been shown to increase the prevalence and recurrence of BPPV.  Degenerative changes 
in the otolith organs are seen in people with diabetes. Hence, people with BPPV and diabetes 
may require repeat treatments for symptom resolution. We hypothesized that more canalith 
repositioning maneuvers would be required for resolution of vertigo in people with BPPV and 
diabetes (Hypothesis 6).  We hypothesized that after complete resolution of vertigo; daily 
function (Hypothesis 7), mobility (Hypothesis 8) and postural sway (Hypothesis 9) would not 
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improve to the same extent in people with BPPV and diabetes compared to people with BPPV 
only. 
 Based on the results of the specific aims above, we have three experimental papers. 
Chapter 3 describes the effect of diabetes on the otolith organs and the results of the vestibular 
evoked potential studies (Aim 2; hypothesis 4 and 5).  In Chapter 4, we included data from 
hypothesis 3 of Aim 1, where we examined postural sway in people with BPPV and those with 
BPPV+DM. The scope of the study was expanded to include controls and people with T2D 
(from Aim 2), so that we could compare postural sway among controls, people with T2D, people 
with BPPV and those with BPPV+DM. In Chapter 5, we provide the combined results of Aim1 
(hypothesis 1, 2, 3) and Aim 3 (hypothesis 6, 7, 8 and 9), so that we could succinctly show 
differences in symptom severity, mobility and balance, between people with BPPV and 










Chapter 3 Preface 
 
Benign paroxysmal positional vertigo is a vestibular condition resulting from 
degeneration of the otolith organs. Diabetes has been shown to cause degeneration of the saccule 
and utricle. However, the combined effect of BPPV and diabetes on the saccule and utricle is not 
clear. In Chapter 3, which is our first experimental chapter related to Aim 2 of the study, we 
examined the otolith organs, using vestibular evoked myogenic potential (VEMP) tests. In this 
study, we analyzed and compared otolith function in people with BPPV and diabetes 
(BPPV+DM), to those with BPPV only, diabetes only, and controls. Our hypothesis was that 
people with BPPV+DM would have a higher frequency of abnormal responses, longer latency 
and smaller amplitude of cVEMP and oVEMP responses compared to all other groups. We 
examined the relationships between VEMP variables and diabetes-related variables.  
 Results of this study showed that people with type 2 diabetes, BPPV and BPPV+DM had 
a higher frequency of abnormal saccule responses compared to controls. Higher HbA1c levels 
were associated with prolonged saccule latency. We did not see a higher frequency of abnormal 
responses on the oVEMP across all four groups. Although, BPPV and T2D independently 
affected utricle and saccule function, they did not appear to have a distinct cumulative effect. 
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Objective: Vestibular dysfunction is a newly recognized complication of type 2 diabetes (T2D) 
that is known to increase fall risk. The prevalence of benign paroxysmal positional vertigo 
(BPPV) is higher in people with T2D. The impact of T2D on the otolith organs of the vestibular 
system in people with BPPV is unknown. The purpose of this study was to analyze otolith 
function using vestibular evoked myogenic potential (VEMP) tests in people with T2D and 
concurrent BPPV (BPPV+DM), and to examine the relationships between VEMP variables and 
diabetes-related variables. 
Study Design: Prospective, cross-sectional study. 
Setting: Tertiary academic medical center 
Subjects and Methods: Participants 40-65 years, were recruited in four groups: controls (n=20), 
people with T2D (n=19), BPPV (n=18), and BPPV+DM (n=14). Saccule and utricle function 
were examined using cervical VEMP (cVEMP) and ocular VEMP (oVEMP), respectively. 
Diabetes related variables such as HbA1c, duration of diabetes and presence of diabetic 
peripheral neuropathy were collected. 
Results: The frequency of abnormal cVEMP responses were higher in the T2D (p=0.005), 
BPPV (p=0.003), and BPPV+DM (p<0.001) groups compared to controls. In the participants 
with diabetes, higher HbA1c levels were correlated with prolonged P1 (p=0.03) and N1 latencies 




Conclusion:  Although, BPPV and T2D may independently affect utricle and saccule function, 
they do not appear to have a distinct cumulative effect. Examining the extent of otolith 




















Presently, type 2 diabetes affects 9.3% of the United States population
1
 and is predicted 
to affect 1 in 3 people by the year 2050.
2
 Diabetic complications such as peripheral neuropathy 
and retinopathy contribute significantly to balance deficits, increasing fall risk.
26, 121
 Emerging 
evidence has shown that vestibular dysfunction may be considered another possible complication 
of diabetes.
7, 8, 122
 In people with diabetes and vestibular dysfunction, the risk of falls increases 
more than two times, even after adjusting for peripheral neuropathy and retinopathy.
8
  Fall 
prevention is a major clinical focus for people with diabetes, hence examining the effect of 
diabetes on the vestibular system merits attention. 
Within the peripheral vestibular system, animal studies have shown that diabetes affects 
the saccule, causing morphological changes, such as type 1 hair cell loss.
10, 35
 In addition, clinical 
research has shown that in people with type 2 diabetes (T2D), utricle and saccule function is 
significantly impaired compared to age matched, healthy controls.
123, 124
 Microangiopathy and 
arteriosclerosis due to hyperglycemia and hypertension are known to cause degeneration of the 
macula of the utricle and saccule.
125, 126
 Degeneration of the maculae of the utricle and saccule 
can cause otoconia fragments to dislodge, which is the cause of one common peripheral 
vestibular condition, benign paroxysmal positional vertigo (BPPV).
67, 127
 Recent studies have 
shown that BPPV is present in higher frequency in people with both type 1 and type 2 diabetes 
compared to healthy controls.
43, 49
  
Vestibular evoked myogenic potentials (VEMP) are objective, clinically reproducible, 
and reliable electrophysiological tests that measure otolith function.
128
 The cervical VEMP 





while the ocular VEMP (oVEMP) arises from acoustic stimulation of the utricle and the superior 
branch of the vestibular nerve.
131, 132
 VEMP studies have been used to identify abnormal 
responses in people with BPPV, where a significantly higher frequency of abnormal cVEMP 
responses,
133-136
 as well as oVEMP responses
137-139
 are seen, compared to age matched controls. 
A few studies have also shown VEMP abnormalities in people with diabetes.
123, 124, 140, 141
 To 
date, there have been no studies that have examined the effects of BPPV and type 2 diabetes 
(BPPV+DM) on the utricle and saccule.  
The primary objective of this study was to analyze differences in otolith organ function in 
people with BPPV+DM compared to controls, people with diabetes only and people with BPPV 
only, using VEMP testing. Our hypothesis was that people with BPPV+DM would have a higher 
frequency of abnormal responses, longer latency, smaller amplitude, and higher threshold of 
cVEMP and oVEMP responses compared to all other groups. A secondary aim was to examine 
the association between otolith dysfunction and variables that indicate severity of diabetes such 
as glycemic control (HbA1c), duration of diabetes, and the presence of diabetic peripheral 
neuropathy.  
This study examines the extent of damage to the otolith organs in people with 
BPPV+DM. Otolith organ dysfunction has been shown to increase postural instability;
61
 hence, 
examination of the otolith organs may help with understanding fall risk factors in adults with 
diabetes.    
3.3 Methods  
 
3.3.1 Study Design: 
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This was a single center, prospective study with a sample of convenience, conducted at a 
University neuro-otology clinic. The research protocol was approved by the Human Subjects 
Committee at the University of Kansas Medical Center. All participants signed the institutionally 
approved written informed consent prior to participation in the study.   
3.3.2 Participants: 
Participants who were 40 to 65 years of age were recruited into four groups: healthy 
controls (n=20), people with type 2 diabetes without vestibular problems (T2D) (n=19), people 
with unilateral, posterior canal BPPV canalithiasis without type 2 diabetes (BPPV) (n=18), and 
those with unilateral posterior canal BPPV canalithiasis and type 2 diabetes (BPPV+DM) 
(n=14). Our recruitment strategies included physician referral, study advertisements, and two 
registry programs for research participants. Participants were excluded if they had (1) a history 
of neurological disease including stroke, multiple sclerosis, Parkinson’s disease, intracranial 
tumor, (2) a history of Meniere’s disease, had bilateral BPPV, anterior or horizontal canal BPPV, 
or cupulolithiasis, (3) received chemotherapy or ototoxic and/or neurotoxic medications, (4) 
traumatic head injury, or (5) conductive hearing loss. Participants with T2D did not have a prior 
medical diagnosis of a vestibular condition, while controls did not have a recorded medical 
history of a vestibular disorder or T2D. 
A detailed medical history was collected and BMI, presence or absence of diabetes and 
hypertension, and medication list were confirmed through electronic health records, if available. 
Glycosylated hemoglobin (HbA1c) via a disposable finger stick testing kit (Metrika A1cNow
+ 
Bayer, Tarrytown NY) was collected. In participants with T2D, additional history regarding 
duration of diabetes and history of diabetic peripheral neuropathy was collected. In addition, all 
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participants were screened for the presence of diabetic peripheral neuropathy (DPN) using the 
Michigan Neuropathy Screening Instrument (MNSI), and were classified as neuropathic if their 
physical exam score was ≥ 2.0.
69
  
For participants with BPPV, inclusion was determined based on a diagnosis of unilateral 
posterior canal BPPV canalithiasis, made by a physician and confirmed by a physical therapist 
(LD). The diagnosis of BPPV was made using videonystagmography (Micromedical, Visual 
Eyes 2002), and was based on the presence of torsional, up-beating nystagmus in the Dix-
Hallpike position, which had a brief latency, lasted less than 60 seconds and reversed with 




All participants were examined using air conducted cVEMP and oVEMP (Biologic 
Auditory Evoked Potentials Navigator Pro- Version 6.2.1), using self-adhesive, silver/ silver 
chloride ECG monitoring electrodes (Tracer rite Bio-Detek Inc.). We scrubbed the skin to 
maintain the impedance of the recording electrodes below five kOhms. Responses to 150 sweeps 
were averaged and two trials were performed to verify the reproducibility of the waveform. For 
consistency, one investigator (LD) performed all the VEMP tests and a second evaluator (CM) 
confirmed absent responses.  
Cervical VEMP testing (cVEMP): 
The cVEMP was performed with the participant seated in an upright position. During 
testing, participants turned their head away from the ear being tested, while they pushed their 
chin against a blood pressure cuff that had been inflated to 20 mm of Hg. They were required to 
push against the cuff, until the pressure reached 40 mm of Hg, while holding the dial so that they 
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could maintain the pressure, in order to monitor muscle contraction.
142, 143
 The primary electrode 
was placed over the mid-point of the ipsilateral sternocleidomastoid muscle, the secondary on the 
upper forehead and ground electrode on the lower forehead. The acoustic stimulus (tone burst, 
500 Hz, 95 dB HL, rate 4.3/sec, rise/fall: 2 ms, plateau: 0 ms), was delivered using insert 
earphones. The EMG signal was amplified (1000x), and band-pass filtered (10-1500 Hz). The 
first positive deflection was marked P1 and first negative deflection N1. Threshold was 
determined next by decreasing the sound volume, and noting the lowest level at which a 
reproducible waveform was recorded.   
Ocular VEMP testing (oVEMP):  
For the oVEMP test, participants were sitting upright; and they were instructed to 
maintain an upward gaze of approximately 30 degrees, on a pre-marked visual target. The 
primary electrode was placed below the lower lid margin of the contralateral eye; the secondary 
electrode above the eyebrow and the ground at the sternum. The acoustic stimulus (tone burst, 
500 Hz, 125 dB SPL, rate 5.0/sec, rise/fall: 1 ms, plateau: 2 ms), was delivered using insert 
earphones. The EMG signal was amplified 5000x and band-pass filtered 1-1000 Hz. The first 
negative deflection was labeled as n10 and first positive deflection p16.  
3.3.4 Data Processing:  
Latencies of the VEMP components were defined as the time from stimulus onset to the 
peak of the waveform. The amplitude was defined as peak-to-peak distance of P1-N1 for 
cVEMP, and n10-p16 for oVEMP. The mean± 2 standard deviation for healthy controls was 
defined as a normal range of responses for the equipment and procedures used in this study. 
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Responses were defined as abnormal if latencies were greater than this normal range, or if 
responses were absent (i.e. if there was no recognizable or reproducible waveform).  
 Testing was completed on both ears for all participants. For participants with BPPV or 
BPPV+DM, the affected ear was defined as the ear that caused symptoms of vertigo and 
nystagmus with the Dix-Hallpike testing. For T2D and control groups, the right and left ears 
were both considered unaffected. After excluding absent VEMP responses, we examined 
differences in latency, amplitude, and threshold between right and left ears and 
affected/unaffected ears using ANOVA. As no differences in latency, amplitude, and threshold 
were found between the right and left ears in all groups as well as between the affected/ 
unaffected ears of participants with BPPV and BPPV+DM, data from each ear were treated as 
individual data points in the analysis.  
3.4 Statistical Analysis 
 
Descriptive statistics (mean, standard deviation, %) were used to examine participant 
demographics in each group. Group differences in participant demographics were tested using 
ANOVA for significant variables and Tukey’s procedures for post-hoc pairwise comparisons 
between groups. Chi-square tests were used to determine differences in the frequency of 
abnormal responses between groups. Differences in HbA1c and duration of diabetes between 
participants with normal responses and those with absent or delayed responses in the diabetes 
groups were examined using ANOVA. After excluding absent VEMP responses, we examined 
the latency, amplitude, and threshold of VEMP responses for normality and equality of 
variances, and compared them across groups using ANOVA for normally distributed variables 
and Kruskal-Wallis test for P1 and N1 latency and the amplitude of oVEMP. In the two groups 
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of participants with diabetes (T2D and BPPV+DM), the relationships between age, sex, BMI, 
hypertension, HbA1c, years with T2D, and MNSI physical scores and each cVEMP and oVEMP 
variable were examined using multiple linear regression models. A p-value <0.05 was considered 
statistically significant. We used SPSS for Windows version 20.0 (SPSS Inc., Chicago, USA) for 
statistical analysis.    
3.5 Results 
 
Seventy-one individuals participated in the study in four groups: healthy controls (n=20), 
T2D (n=19), BPPV (n=18) and BPPV+DM (n=14). HbA1c, BMI, and the prevalence of 
hypertension were significantly higher in the groups with diabetes (Table 1).  










Age (years) 57.5 ± 5.3 
 
58.6 ± 5.3 54.9 ± 5.9 58.5 ± 5.6 p=0.17 
Gender (M/F) 6/14 5/14 4/14 5/9 p=0.84 
HbA1c (unit-%) 5.3 ± 0.3 
 
7.8 ± 1.7 5.6 ± 0.4 7.1 ± 1.5 p<0.01* 
BMI (kg/m
2
) 26.9 ± 5.3 
 
35.4 ± 6.3 29.5 ± 8.1 37.4 ± 5.2 p<0.01* 
Hypertension 
(%) 




- 11 (58%)  7 (50%)  
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Years with T2D - 10 ± 8.8 - 10.6 ± 11  
HbA1c= glycosylated hemoglobin, BMI= body mass index. Continuous variables are described as mean ± 
SD, categorical variables as count (percentages). p values are based on chi square tests for frequencies 
and ANOVA for continuous variables. 
 
3.5.1. Frequency of abnormal VEMP responses:   
cVEMP responses:  
In the healthy control group, thirty-eight ears showed a normal cVEMP response. The 
normal range for P1 latency (mean±2SD) was 13.5-19.4ms, and N1latency was 21.8- 27.52ms. 
Based on these findings, the P1 and N1 responses in all four groups were classified as normal, 
delayed, or absent. We observed significant differences in the frequency of abnormal responses 
between the T2D, BPPV and BPPV+DM groups, when compared to controls (Table 2). There 
were no differences in the frequency of abnormal responses between any of the other groups 
(T2D, BPPV, and BPPV+DM).  
Table 2: Frequency of abnormal cVEMP responses in each group based on P1 and N1 
latency  







(n= 40 ears) 
1 0 0 1 2 (5%) 
Type 2 diabetes  
(n= 38 ears) 
3 3 0 5 11 (28.9%) 
p=0.005* 
  








chi square tests were conducted. * Significant differences between controls and the three other groups 
noted. BPPV- benign paroxysmal positional vertigo, BPPV+DM- BPPV and type 2 diabetes 
  
In the two diabetes groups examined (T2D and BPPV+DM, n=33), 15 participants had 
absent or delayed responses in at least one ear (45.5%). In these participants, the mean HbA1c 
was 8.3 ± 1.7% compared to 6.8 ± 1.2% in participants with normal responses (p=0.006); the 
mean time since diagnosis of diabetes was 8.0 ± 10.2 years compared to 4.7 ± 6.2 years in those 
with normal responses (p=0.27). Figure 1 illustrates the cVEMP responses of a participant in 




Figure 1: Tracings of the cVEMP responses in the left ear of four participants, one from 
each group, matched by age and sex. T2D- type 2 diabetes, BPPV- benign paroxysmal positional 
vertigo, BPPV+DM- BPPV and diabetes 
oVEMP responses:  
In the healthy control group, thirty-four ears showed a normal oVEMP response. The 
normal range for n10 latency was 8.6-13.3ms and p16 latency was 14.0-18.7ms. No differences 
were noted in the frequency of abnormal responses between any groups (p=0.2) (Table 3). 
Table 3: Frequency of abnormal oVEMP responses in each group based on n10 and p16 
latency  






Control   
(n= 40 ears) 
1 1 0 4 6 (15%) 
Type 2 diabetes  
(n= 38 ears) 
2 1 1 9 13 (34%) 
(p=0.05) 




3 0 0 6 9 (32%) 
(p=0.08) 
Chi-square tests were used to compare frequency of abnormal responses across groups. BPPV-benign 
paroxysmal positional vertigo, BPPV+DM- BPPV and type 2 diabetes 
 
 In the two groups of participants with diabetes (T2D and BPPV+DM, n=33), 17 had 
delayed or absent oVEMP responses (51.5%), in at least one ear. The mean HbA1c in these 
participants was 8.0 ± 1.8% compared to 6.9 ± 1.2% (p=0.06); mean time since diagnosis of 
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diabetes was 7.9 ± 9.6 years compared to 4.4 ± 6.4 years, in participants with normal responses 
(p=0.24). Figure 2 illustrates the oVEMP responses from a participant in each group. 
 
Figure 2: Tracings of the cVEMP responses in the left ear of four participants, one from 
each group, matched by age and sex. T2D- type 2 diabetes, BPPV- benign paroxysmal positional 
vertigo, BPPV+DM- BPPV and diabetes 
3.5.2 Comparison of VEMP variables across groups: 
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After excluding participants with absent responses, there were no differences in the 
cVEMP P1 and N1 latency, amplitude, or threshold between the four groups. Significant 
differences were found in oVEMP n10 latency between groups (p=0.03); post hoc tests showed 
that the T2D group had prolonged n10 latency compared to the control group.  Significant 
differences were seen in amplitude between groups (p=0.01), with a smaller amplitude in the 
T2D group compared to the BPPV group (Table 4). 
Table 4: Comparisons of the oVEMP variables  
 n10 latency (ms) p16 latency (ms) Amplitude (µV) 
Control  (n=36 ears) 10.9 (1.1) 16.4 (1.2) 9.5 (7.5) 
T2D (n=29 ears) 11.8 (1.0) 16.9 (1.3) 8.1 (3.4) 
BPPV (n=26 ears) 11.4 (1.3) 17.3 (1.5) 13.5 (7.3) 






Bonferroni procedure showed significant difference between the control and the T2D group. 
b 
Kruskal-
Wallis test showed significant differences in amplitudes between the BPPV group and the T2D group 
T2D- type 2 diabetes, BPPV-benign paroxysmal positional vertigo, BPPVDM- type 2 diabetes and 
concurrent BPPV  
 
 
3.5.3 Relationships between VEMP variables and diabetes variables: 
cVEMP variables: In the two groups of participants with diabetes (T2D and BPPV+DM), 
cVEMP responses were recorded in 56 ears. We examined the relationship between age, sex, 
BMI, HbA1c, hypertension, MNSI physical score, years with diabetes and cVEMP variables. P1 
latency (r=0.44) was associated with BMI (p=0.001) and HbA1c level (p=0.05), while N1 
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latency (r=0.5) was associated with HbA1c level (p=0.01). Threshold (r=0.49) was associated 
with HbA1c level (p=0.04) and MNSI physical score (p=0.003).   
oVEMP variables: In the diabetes groups (T2D and BPPV+DM, n= 51 ears with responses), we 
examined the relationship between age, sex, BMI, HbA1c, hypertension, MNSI physical scores, 
years with diabetes, and oVEMP variables. Significant associations were seen between the 
amplitude of oVEMP (r=0.61) with age (p=0.009), and hypertension (p=0.04).  
3.6 Discussion 
 
The results of this study reveal a higher prevalence of abnormal cervical VEMP 
responses in people with T2D, BPPV, and both BPPV and T2D as compared to healthy people of 
similar age. Contrary to our hypothesis, people with BPPV+DM did not have a higher frequency 
of abnormal cVEMP responses compared to people with either T2D or BPPV only. The 
frequency of abnormal cVEMP responses in BPPV (30.6%) is similar to observations made by 
others.
134, 135
 After excluding absent VEMP responses from the analysis, our study found no 
differences in latency, amplitude, or threshold between the groups. This finding differs from 
Hong et al
133
 who found that 75% of their participants with BPPV had prolonged P1 latencies, 
compared to healthy controls. This difference may be due to the participants recruited for their 
study, who had BPPV in any canal in a wide age range (20 to 81 years); advancing age is 
associated with prolonged VEMP latencies.
144
  
Our findings of a 28.9% abnormal cVEMP response rate in people with T2D are similar 
to other studies,
123, 124
 however, unlike those studies, we did not see prolonged latencies or 
reduced amplitude when we compared people with diabetes who had cVEMP responses to our 
control group. The main difference between this study, and the one by Ward et al,
123
 is that their 
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participants were older with a 10-year or longer history of T2D. We did see a relationship 
between prolonged latency of P1 and N1 with higher HbA1c levels.  
When participants with T2D and BPPV+DM were examined, we found that 45.5% had 
absent or delayed responses, with a significantly higher HbA1c level in people with abnormal 
responses. Degeneration of the macula of the saccule, with hair cell loss, is one suggested cause 
for detachment of the otoconia, causing BPPV,
145, 146
 while degeneration of the vestibulocochlear 
nerve; particularly the inferior vestibular nerve has been observed in BPPV. These 
pathophysiological mechanisms of damage have been seen in experimentally induced diabetic 
rats, where histopathological changes due to metabolic stress may be the cause of degeneration 
of type 1 hair cells in the saccule.
35
 Diabetic rats have been shown to have demyelination of the 
vestibulocochlear nerve  with smaller axonal fiber density.
10
 These morphological changes may 
explain both delayed and absent VEMP responses. Of importance, several studies have shown 
that absent cVEMP responses are indicative of extensive neuronal damage, seen in people with 
chronic and resistive BPPV,
136
 and in people with recurrent BPPV.
138
  
Our study did not find a difference in abnormal cVEMP responses between the T2D, 
BPPV, and BPPVDM groups. This finding is particularly interesting because the individuals 
with T2D did not have a diagnosis or any symptoms of vestibular disease. Other researchers have 
noted a higher frequency of vestibular dysfunction in people with diabetes, who are 
asymptomatic, compared to healthy controls.
9, 40
 Gawron et al
9
 found a higher frequency of 
spontaneous and positional nystagmus in children with type 1 diabetes, particularly in those with 
uncompensated diabetes and a longer duration of diabetes, however, only 6.3% of their 
participants complained of vertigo, imbalance, or both. Ward et al
123
 found that in people with 
T2D, there was no relationship between the frequency of abnormal vestibular responses and the 
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dizziness handicap inventory, which is a questionnaire that assesses the person’s perception of 
handicap due to dizziness. Likewise, even though vestibular dysfunction was evident with 
VEMP testing, Konukseven et al
124
 reported no complaints of dizziness in 70% of people with 
T2D; and in the 30% who did have dizziness the complaints of dizziness were attributed to 
chronic autonomic neural degeneration due to diabetes. Based on these results, it is speculated 
that people with diabetes may have symmetrical involvement of both inner ears with minimal 
complaints of dizziness, as clinical symptoms may be seen only when damage to the vestibular 
system is severe.
37
 Therefore, VEMP studies may be sensitive to diagnose subclinical vestibular 
involvement.  
Analysis of the oVEMP showed no differences in the frequency of abnormal oVEMP 
responses between any groups. This was surprising since utricle dysfunction is prevalent in 
people with BPPV,
137, 139
 and Nakahara et al
137
 found that 66.7% of ears affected with BPPV had 
abnormal responses compared to healthy age-matched controls. However, in their study, 
participants were selected from a wide age range (34 to 82 years), and they took amplitude of the 
oVEMP into account when they examined the frequency of abnormal responses. We classified 
abnormal responses based on the latency of the oVEMP only, because the equipment we used 
did not have the electromyography capability to correct for baseline variations in ocular muscle 
activity.  
Comparisons of oVEMP latency across groups showed significantly prolonged n10 
latency in the T2D group compared to controls. Our results are similar to two recent studies that 
have examined the oVEMP in people with T2D showing prolonged latency of n10
123, 124
 
compared to healthy, age matched controls. Our study also found a significant decrease in the 





reported that 46% of their participants with BPPV had augmented oVEMP amplitudes, and have 
speculated that because the otoconia are detached, the same sound volume may cause greater 
oscillation of the otolith membrane, producing a larger oVEMP response. It is possible that T2D 
may cause a decrease in amplitude of the oVEMP; however, the literature on the effect of T2D 
on the amplitude of the oVEMP is conflicting.
123, 124
 
We did not find associations between oVEMP and diabetes variables in participants with 
T2D and those with BPPV+DM.  T2D did not appear to affect the utricle as clearly as it did 
saccule, a result that is supported by a recent study by Konukseven et al,
124
 who speculated that 
hyperglycemia may not affect the superior vestibular nerve, or the oVEMP compensation may be 
quicker.  
The main limitation of this study is the small sample size, particularly in the BPPV+DM 
group; however, because of the strict inclusion criteria we were able to focus our attention to 
people with BPPV in a single canal, with canalithiasis only. Based on the study design, we 
cannot determine the causal relationship between diabetes and vestibular dysfunction in people 
with BPPV, because the presence of other medical conditions like migraine and post-menopausal 
status, which are known to increase the degeneration of the otolith organs, was not matched 
between groups. We did not perform a neurootologic examination of the healthy controls and 
people with T2D only. Although, they did not report complaints of dizziness and their medical 
records did not indicate vestibular disease, they could have had subtle vestibular deficits.  
Ultimately, the interest in examining otolith function is to determine how this finding 
may affect a person’s mobility and quality of life. Of all the vestibular organs, the otolith organs 
provide the primary vestibular contribution to postural control.
147
 People with BPPV have been 
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shown to have otolith organ dysfunction,
134, 137
 which is bilateral and does not improve even after 
successful repositioning.
148
 Otolith dysfunction is associated with postural instability and higher 
risk for falls.
66, 149, 150
  Our study showed that otolith dysfunction was present in people with 
diabetes. In people with diabetes, who have vestibular dysfunction and complaints of dizziness, 
the risk of falling is two times higher, independent of peripheral neuropathy and retinopathy.
7
 In 
addition, people with diabetes are prone to developing diabetic complications, of which diabetic 
peripheral neuropathy and retinopathy increase the risk of falls.
24, 26, 121
 Understanding the impact 
of multiple sensory deficits i.e. visual, vestibular and somatosensory, and their relative 
contribution to fall risk could help in developing strategies to prevent falls.   
3.7 Conclusion 
 
T2D is a common comorbidity that affects the vestibular system in addition to other body 
systems and organs. This study showed that both adults with BPPV and those with T2D have 
abnormalities in otolith responses; but diabetes may have a stronger effect on the saccule than 
the utricle. Future studies examining the incidence of falls in people with BPPV+DM who have 
abnormal VEMP responses, will help elucidate the relationship between otolith dysfunction and 








Chapter 4 Preface 
In Chapter 3, we examined otolith organ function to determine the effect of BPPV and 
diabetes on the otolith organs of the vestibular system. Otolith dysfunction is associated with 
postural instability and a higher fall risk. Hence, the primary objective of the study described in 
Chapter 4 was to examine postural sway in people with BPPV and diabetes (BPPV+DM), in 
different visual and standing support conditions, using accelerometry. This study was initially 
conceived as hypothesis 3 of Aim 1, to examine sway in people with BPPV and BPPV+DM 
only. We expanded the scope of our data collection to include healthy controls and people with 
diabetes (without vestibular dysfunction). This study design allowed us to compare people 40 to 
65 years of age, with BPPV and BPPV+DM to healthy controls and people with diabetes, using 
our specific accelerometry study procedure and the conditions that we were interested in 
examining.  
As both, diabetes and BPPV are known to increase postural sway in challenging 
conditions, our original hypothesis was that people with BPPV+DM, would have higher sway 
values compared to people with BPPV only. After we added the control and diabetes groups, our 
hypothesis was that people with BPPVDM, would have higher sway values compared to patients 
with BPPV only, type 2 diabetes only and healthy controls. Our second objective was to identify 
which specific conditions of postural stability would be more challenging for people with 
BPPV+DM.  
 Results of this experimental study showed that the range and velocity of postural sway 
measures were significantly higher in people with BPPV+DM compared to people with diabetes 
and controls, particularly in the anteroposterior direction. In people with BPPV+DM, 
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significantly higher sway was seen when standing on foam with eyes closed and in tandem 
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Background and Purpose: Diabetes has been shown to affect the peripheral vestibular end 
organs and is associated with an increase in the frequency of benign paroxysmal positional 
vertigo (BPPV). People with diabetes have higher postural sway; however, the impact of 
concurrent BPPV on postural sway, in these individuals is unclear. The purpose of this 
prospective study was to examine postural sway in people with type 2 diabetes and concurrent 
BPPV (BPPV+DM).  
Methods:  Fifty-two participants (mean age 56.9 ± 5.6 years) were enrolled: controls (n=14), 
diabetes (n=14), BPPV only (n=13) and BPPV+DM (n=11). We used an inertial motion sensor 
to detect pelvic acceleration across five standing conditions with eyes open/closed on varied 
surfaces. Range of acceleration (cm/s2
)
, peak velocity (cm/s), and variability of sway (RMS), in 
anterior-posterior (AP) and medial-lateral (ML) directions were used to compare postural sway 
between groups across the conditions.    
Results: Participants with BPPV+DM had higher range of acceleration in AP (p=0.003) and ML 
(p=0.006) directions, as well as higher peak velocity (p<0.001) and RMS values (p=0.006) in the 
AP direction compared to the control and diabetes groups. Standing on foam with eyes closed 
and tandem stance conditions were the most challenging conditions for people with BPPV+DM.  
Discussion and Conclusion: Clinicians may consider using standing on foam with eyes closed 
and tandem stance positions to assess postural control in people with BPPV+DM. Education on 
increasing the use of visual or sensory feedback, particularly on uneven surfaces, may help to 





In people with type 2 diabetes, complications such as peripheral neuropathy and retinopathy 
are frequently cited as the cause of increased postural sway and falls.
24, 26, 121
 Although vestibular 
dysfunction is not commonly recognized as a microvascular complication of diabetes, there is 
substantial evidence of reduced central and peripheral vestibular function in people with type 1 
and type 2 diabetes.
9, 39, 41, 123, 151
  In people with diabetes, the presence of vestibular dysfunction 
has been shown to increase fall risk more than two times, even after adjusting for peripheral 
neuropathy and retinopathy.
8
   
Among the peripheral vestibular organs, the otolith organs of the inner ear, namely the utricle 
and saccule, have shown morphological changes and loss of hair cells in experimentally induced 
diabetic rats,
35
 while clinical research has shown that 50% of people with type 2 diabetes have 
otolith organ impairment.
123
  The prevalence and recurrence of one specific vestibular condition, 
benign paroxysmal positional vertigo (BPPV), has been shown to be higher in people with 
diabetes.
43, 49, 50
   BPPV results when otoconia, which are calcium carbonate crystals, detach from 
the utricle and saccule, and end up either free floating in the semicircular canals or attached to 
the cupula.
152, 153
 Degeneration of the otolith organs is one reason for the detachment of the 
otoconia.
88, 94
 BPPV causes vertigo which is dependent on the position of the head relative to 
gravity, has a short latency, and is transient; and is associated with loss of balance and frequent 
falls.
154-156
  People with BPPV have been shown to have increased postural sway compared to 
healthy controls, particularly in conditions with altered proprioception and vision.
157, 158
 In 
addition, dynamic balance is affected, where people with BPPV have slower walking speed 





Kinetic analysis of posture has been used to quantify postural stability in healthy individuals, 
older adults, as well as people with orthopedic, neurologic and vestibular disease.
159-162
  These 
studies usually include quiet standing in single or double stance on a force platform while the 
different sensory systems (visual, vestibular and somatosensory) of these individuals are 
perturbed.
22, 163-166
  More recently, studies have used an accelerometer positioned near the center 
of mass, to measure postural sway quantitatively.
167-169
  Accelerometry has high criterion validity 
(r=0.92), and excellent test-retest reliability (r=0.80) when compared to center of pressure 
measures, using force platforms.
170-172
 One-30 second trial of accelerometry has been shown to 
be as useful as three trials, to capture postural sway. 
171
 Accelerometry has the ability to 
discriminate between various test conditions, as the complexity of the task increases
169, 173
 and is 
able to differentiate between fallers and non-fallers with a sensitivity of 58.3% and specificity of 
80%.
174
 Time sensitive accelerometry measures that are used to characterize postural sway 
include range of acceleration, root mean square of acceleration and peak velocity.
171, 174, 175
 
The primary objective of this study was to examine postural sway in people with type 2 
diabetes and concurrent BPPV (BPPV+DM), in different visual and standing support conditions, 
using an accelerometer. Our hypothesis was that people with BPPV+DM, would have higher 
sway values compared to people with BPPV only, type 2 diabetes only and healthy controls. Our 
second objective was to identify which specific conditions of postural stability would be more 
challenging for people with BPPV+DM. We hypothesized that people with BPPV+DM would 
have greater difficulty maintaining a stable position in conditions with reduced visual and 
somatosensory information, due to a co-existing disturbance in the vestibular system. Results of 
this study will be important to help clinicians understand the effect of underlying sensory deficits 
and their impact on postural stability in people with BPPV+DM. Making patients aware of their 
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postural instability in challenging conditions could serve as an effective education tool. For 
example, they may learn to avoid situations of daily life that are challenging due to reduced 




4.3.1 Study Design: 
This was a single-center, prospective study with a sample of convenience. The research 
protocol was approved by the Human Subjects Committee at the University of Kansas Medical 
Center. Institutionally approved written informed consent was obtained from all individuals prior 
to participation in the study.  
4.3.2 Participants: 
Participants between 40 to 65 years were recruited and allocated to four groups: healthy 
controls, individuals with type 2 diabetes without vestibular problems (type 2 DM), individuals 
with BPPV without diabetes (BPPV), those with both type 2 diabetes and BPPV (BPPV+DM). 
Participants were recruited through physician referral, study advertisements, and two research 
participant registry programs. For the BPPV and BPPV+DM groups, only people with unilateral 
posterior canal BPPV canalithiasis were included in the study. The diagnosis of BPPV was made 
based on the presence of up beating torsional nystagmus in the Dix-Hallpike position with a brief 
latency, nystagmus lasting less than 60 seconds and reversed upon sitting, with associated 
complaints of vertigo,
67
 determined by a physician and confirmed by a physical therapist, using 
videonystagmography.   
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The presence or absence of diabetes was confirmed through the individual’s medical 
records. In addition, glycosylated hemoglobin (HbA1c) information was collected via a 
disposable finger stick testing kit (Metrika A1cNow
+ 
Bayer, Tarrytown NY). Participants with 
type 2 diabetes did not have a medical diagnosis of vestibular problems and no complaints of 
dizziness. The control group did not have a medical history of vestibular disease or diabetes.   
All participants were screened for the presence of diabetic peripheral neuropathy (DPN), 
using the Michigan Neuropathy Screening Instrument (MNSI), which has a questionnaire and 
physical exam components. Participants were classified as neuropathic if their physical exam 
score was ≥ 2.0.
69
  
Participants in all groups were excluded if they had a (1) history of neurological disease 
including stroke, multiple sclerosis, Parkinson’s disease, or intracranial tumor, (2) history of 
Meniere’s disease, (3) received chemotherapy or ototoxic and/or neurotoxic medications, (4) 
traumatic brain injury, or (5) musculoskeletal or integumentary  conditions that would impair 
balance testing.   
 
4.3.3 Materials and Procedure:  
 In a single testing session, participants were assessed in quiet standing in the feet together 
position for 30 seconds. The 5 testing conditions were: (1) standing on a firm surface with eyes 
open, (2) on a firm surface with eyes closed, (3) on a foam pad (Alimed balance pad elite) with 
eyes open, (4) on a foam pad with eyes closed, and (5) tandem stance with eyes open on a firm 
surface (Figure 1). A physical therapy student guarded all participants during the testing. Each 
condition was explained and demonstrated to participants, and were performed in the same order 
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for all participants. The recording was started at the signal “ready, set, and go” and stopped after 
counting backwards from 3. All participants wore their regular shoes during testing to avoid 
provoking their dizziness due to bending down to remove their shoes. Whitney et al
176
 have 
shown that balance testing can be performed with or without shoes on, with no significant 
change in sway measures. One 30-second trial was conducted in each testing position. 
Participants were advised to open their eyes or reach for the person guarding them, if they lost 
their balance. If a participant lost their balance or opened their eyes during a particular condition, 
they were given another opportunity to retest that position. During the tests, pelvic accelerations 
were measured using an inertial motion sensor (Xsens North America, USA) sized 5.25 x 3.75 x 
2 cm. The sensor was held firmly in place over the posterior aspect of the third vertebra of the 
lumbar spine using an elastic belt provided by the manufacturer (Figure 1).   
 
                                        
Figure 1: The five experimental conditions used to examine postural sway. The inertial 
sensor was positioned at L3 spine level, displayed in the inset picture. 
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4.4.4 Data Processing: 
 Data was acquired using the MT Manager software (Xsens North America, USA) at a 
sampling frequency of 120 Hz. The three-axial (X, Y, and Z) acceleration data was recorded 
during the 30 seconds of data collection. The accelerations in Y and Z directions, corresponding 
to medial-lateral (ML) and anterior-posterior (AP) directions respectively, were used to calculate 
the variables that represented postural sway. The data was filtered using a second order, 
Butterworth low-pass filter at 20 Hz and corrected for offset.  
The following variables were calculated and used for statistical analysis: (1) Range (cm/s
2
) – 
the peak-to-peak amplitude of acceleration, in AP (Range-AP) and ML directions (Range –ML). 
(2) Peak velocity (cm/s) in AP (PV-AP) and ML (PV-ML) directions, velocity was calculated by 
integrating the acceleration. (3) Root mean square (RMS) which is the dispersion of the 
acceleration traces in AP (RMS-AP) and ML (RMS-ML) directions. All variables were 
calculated using customized Matlab code (The Mathworks Inc., Natick, MA).  
4.5 Statistical Analysis  
 
Descriptive statistics (mean, standard deviation, %) were used to present participant  
demographics in each group. Group differences in participant demographics were tested using 
ANOVA for significant variables and Tukey’s procedures for post-hoc pairwise comparisons 
between groups. Range-AP, range-ML, PV-AP, PV-ML, RMS-AP and RMS-ML were examined 
using a general linear mixed model method. We used compound symmetric correlation structure 
to take into account within subject correlation due to repeated measures. The conditions were 
entered as within subject factor, while groups were entered as between subject factor. The 
condition by group interaction was to evaluate the group differences within conditions. For a 
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significant model, post hoc comparisons were done using Tukey’s method for multiple 
comparisons. In those trials in which participants were unable to complete the test, we used an 
intention to treat model, and values were assigned based on the group mean ± 2SD. Statistical 




We screened 151 individuals and enrolled 52 in the four participant groups: 1) controls 
(n=14), 2) type 2 diabetes (n=14), 3) BPPV (n=13) and 4) BPPV+DM (n=11). The reasons for 
exclusion from the study are outlined in Figure 2.  
 
Figure 2: Participant enrollment flow chart.  
4.6.1 Descriptive statistics:  
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Participant characteristics are summarized in Table 1. HbA1c (p=0.03) and BMI (p<0.01) 
were significantly different in subjects with and without type 2 diabetes. Eight participants in the 
diabetes group and four in the BPPV+DM group had MNSI physical scores ≥ 2.0.  
Table 1: Participant characteristics 
 
Values are presented as mean ± SD or frequency. DM- diabetes, BPPV- benign paroxysmal positional 
vertigo, BPPV+DM- diabetes and concurrent BPPV, DPN-diabetic peripheral neuropathy, BMI-body 
mass index, HbA1c- glycosylated hemoglobin 
 
4.6.2 Postural Sway variables:  
 
One participant in the BPPV+DM group could not stand on foam, eyes closed or tandem 
stance (condition 4 and 5), while another in the BPPV+DM group was unable to complete 
tandem stance, due to loss of balance.   
Range of acceleration:  
Range-AP had a significant main effect of group (F1, 52: 3.5, p=0.02), condition (F 1, 52: 
34.6, p<0.001), and interaction between group and condition (F 1, 52: 2.6, p=0.003). The 
BPPV+DM and BPPV groups had significantly higher range of sway in the AP direction 
 Controls 
(n-14) 









Age (years) 58.07 (4.9) 
  
57.4 (5.5) 54.5 (6.0) 57.6 (5.7) p= 0.34 
HbA1c (%) 5.4 (0.4) 
  
7.8 (1.9) 5.6 (0.4) 6.9 (1.6) p< 0.001 
BMI (kg/m2 ) 27.2 (6.3) 
  
34.0 (5.5) 28.2 (6.5) 36.3 (4.2) p<0.001 







compared to controls and the diabetes group on foam, eyes closed (condition 4) and tandem 
stance (condition 5) (Figure 3).  
 
Figure 3: Mean range and standard errors in anteroposterior (AP) and mediolateral (ML) 
directions for the four groups across the five testing conditions. a and b indicate the significant 
difference between the BPPV+DM and BPPV groups compared to the control and diabetes groups, 
respectively based on testing conditions. c represents the significant difference between the BPPV+DM 
group and the other three groups. 
 
Range-ML had a significant main effect of group (F1, 52: 4.7, p=0.01), and condition (F 1, 
52: 45.3, p<0.001), there was no interaction between group and condition (F 1, 52: 1.5, p=0.13). 
The BPPV+DM and BPPV group had significantly greater ML range on foam with eyes closed 
compared to controls and the diabetes groups, additionally the BPPV+DM group had greater 
range of sway in the ML direction in tandem stance (Figure 3).   
Peak velocity:  
PV-AP showed a significant main effect of group (F1, 52: 7.2, p<0.001), and condition (F1, 
52:18.1, p<0.001), no interaction was seen between group and condition (F1, 52: 1.5, p=0.11). PV-
AP was higher in the BPPV+DM group compared to the control, diabetes, and BPPV groups, 
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when standing on a firm surface with eyes closed and tandem stance. Higher peak velocity of AP 
sway was seen in both the BPPV and BPPV+DM groups when standing on foam with eyes 
closed compared to control and the diabetes groups (Figure 4).  
 
Figure 4: Mean and standard errors of peak velocity in anteroposterior (AP) and 
mediolateral (ML) directions for the four groups across the five testing conditions. a and b 
indicate the significant differences between the BPPV+DM and BPPV groups and the control and 
diabetes groups, respectively. c indicates the significant difference between the BPPV+DM group and the 
3 other groups. 
 
PV-ML showed a main effect of condition (F1, 52: 10.5, p<0.001). The main effect of 
group (F1, 52: 1.9, p=0.1), and interaction between group and condition (F1, 52: 1.2, p=0.3) was not 
significant. Subsequent analysis showed that the peak velocity of sway was greater when 
standing on foam with eyes closed (Figure 4).  
Root Mean Square:  
RMS-AP showed a significant main effect of condition (F 1, 52: 14.73, p<0.001) and 
interaction between group and condition (F1, 52: 2.43, p=0.006). There was no effect of group (F 1, 
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52: 1.32, p=0.28). RMS values were greater in the BPPV group when standing on foam with eyes 
closed, and greater in the BPPV+DM group in tandem stance (Figure 5).  
 
Figure 5: Mean and standard errors of RMS of acceleration in anteroposterior (AP) and 
mediolateral (ML) directions for the four groups across the five testing conditions. c and d 
indicate the significant difference between the BPPV+DM and BPPV groups compared to the three other 
groups, respectively.  
 
RMS-ML showed a main effect of condition (F 1, 52: 37.4, p<0.001). There was no effect 
of group (F 1, 52: 1.2, p=0.26), and no interaction between group and condition (F 1, 52: 0.49, p= 
0.92). Significantly greater RMS in the ML direction was seen when standing on foam with eyes 
closed (Figure 5). 
4.7 Discussion 
 
The present study was designed to examine balance sway in individuals with type 2 
diabetes and concurrent BPPV in various conditions of postural stability. The conditions 
examined are used frequently in the clinic setting to assess the contribution of the vestibular, 
visual and somatosensory systems towards postural stability.
62
 We analyzed pelvic accelerations 
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to detect balance performance, where higher range, peak velocity and variability of sway, are 
indicative of impaired postural stability.
172
 The main findings of our study supported our primary 
hypothesis that individuals with type 2 diabetes and concurrent BPPV would exhibit increased 
postural sway, suggestive of decreased postural stability. Our second objective was to identify 
the specific conditions that would be challenging for people with BPPV+DM. Our hypothesis 
was supported by our study findings, which showed that standing on a complaint surface without 
visual input and tandem stance were the most challenging positions for people with BPPV+DM.  
The vestibular system, along with the visual and somatosensory systems provides 
information about the position and motion of the body with respect to earth’s vertical. In normal 
conditions, information from all sensory systems complement each other, however, if one of the 
sensory inputs is unavailable or deprived, it is critical for the central nervous system to be able to 
extract sensory information from the other available sensory systems (sensory reweighting) to 
maintain postural stability and avoid a fall.
177
 Thus, results of our study suggest that distorted 
inputs from the vestibular system in individuals with BPPV, both with and without diabetes, 
changes the sensory reweighting. This increases postural sway, particularly in conditions in 
which the somatosensory and visual systems are not operating optimally. These results are 
similar to the findings of previous studies using static posturography, which have shown higher 




People with BPPV+DM also experienced difficulty maintaining tandem stance (condition 
5). Tandem stance inherently utilizes the hip strategy rather than ankle strategy for balance 
control. However, use of the hip strategy might possibly be limited in people with BPPV+DM 
since the information being integrated from the somatosensory system does not match the 
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vestibular inputs. People with vestibular problems may also be unable to maintain tandem stance 
due to coexisting somatosensory deficits. Participants with BPPV+DM in this study (36%) 
presented with DPN (see Table 1); hence, it is possible that they were not able to compensate for 
their vestibular deficits due to the reduced somatosensory inputs. In contrast, our group of 
participants with BPPV only, did not have problems balancing in tandem stance, which means 
they could compensate well in tandem standing for their vestibular deficits.  
There is a possibility that people with BPPV+DM may have greater impairment of their 
vestibular system due to a direct effect of diabetes on the vestibular system.
123, 124
 Animal studies 
have shown morphological and physiological changes specifically in the saccule of rats in 
experimentally induced diabetes due to metabolic stress.
10, 35, 37
  Of all the vestibular organs, the 
otolith organs provide the primary vestibular contribution to postural control;
178
 and damage to 
the otolith organs has been shown to affect postural control.
61
  Serrador et al
179
 demonstrated that 
age related loss of otolith function increased postural sway.  A recent study by Ward et al
123
 has 
shown that adults with type 2 diabetes of longer durations (>10 years), have decreased function 
of the peripheral vestibular apparatus, compared to healthy age-matched controls.  Hence, it is 
plausible that increased sway seen in people with BPPV+DM is not only due to the effect of 
diabetes and BPPV independently, but also the effect of diabetes on the vestibular apparatus 
directly. The present study was not designed to examine the impact of diabetes directly on the 
vestibular system, but it can stimulate future studies to investigate the relationship between 
postural sway and direct measures of vestibular function such as calorics or evoked potential 
tests. Altogether, the results of our study provide useful information when screening people with 
BPPV with or without type 2 diabetes. It is likely that both groups of people will have increased 
sway when standing on foam with eyes closed, but people with BPPV+DM will also have 
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significant difficulty maintaining the tandem stance position. In fact, Vereeck et al. have noted 
that tandem walking was much more difficult for older people with vestibular loss than the 
Timed Up &Go (TUG) test and the dynamic gait index.
180
 
 In our study, no differences were found in any measure of balance in individuals with 
type 2 diabetes compared to controls. Previous studies have shown that individuals with type 2 
diabetes, particularly those with diabetic peripheral neuropathy (DPN), have greater range and 
velocity of sway compared to age matched controls, when standing on a firm surface with and 
without visual input.
6, 22, 23, 181
  We found no differences in sway measures in our group with 
diabetes compared to our control population. This difference may be due to the fact, that not all 
of our participants with diabetes had neuropathy as determined by MNSI physical exam scores. 
Although the MNSI is a well-established clinical screening tool to identify people at risk for 
DPN, it is not a gold standard diagnostic test.
182
  
Ultimately, the significance of finding increased postural sway in people with 
BPPV+DM is related to its potential association with functional mobility and fall risk. Although 
the present study cannot answer this question, one study has shown that sway values calculated 
from accelerometry were higher in older adults with lower scores on the Berg balance scale 
(BBS), and those who walked slower on the TUG.
174
  Whitney et al. have shown that people with 
vestibular dysfunction, who score more than 11 seconds on the TUG were five times more likely 
to have had a fall in the previous 6 months.
183
  The BBS assesses balance and postural control 
and is useful to identify people with vestibular dysfunction at a higher risk for falling.
184
 
Therefore, we can reasonably suggest that people with BPPV+DM may have a higher risk of 
falling especially in conditions where the somatosensory and visual feedbacks are deprived, as in 
certain daily activities like walking in the yard or on plush carpet without adequate lighting.  
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BPPV may be considered a complication of type 2 diabetes, and it is frequently 
encountered in clinical settings. Fall prevention is a major focus of the care provided to people 
with diabetes with or without BPPV, since they are prone to fractures and more severe injuries 
after a fall.
27, 28, 30
  Information from this study is pertinent to clinicians working with people with 
diabetes to identify daily life activities that could increase risk of falls, and to make patients 
aware of their balance deficits during balance screening in the clinic. After successful resolution 
of BPPV with the appropriate treatment maneuver, treatment plans need to be developed for 
people with BPPV+DM that include walking programs and balance training on compliant and 
narrow surfaces with and without visual feedback to improve balance performance. 
Limitations 
Admittedly, there are limitations to this study that need to be considered when 
interpreting the results. Our groups did differ significantly in BMI, and higher BMI is known to 
affect postural stability.
185
 However, people with diabetes are known to have higher BMI.
186
 Due 
to small sample sizes, we did not further break down the analysis of the groups with diabetes on 
the basis of diabetic peripheral neuropathy. Future studies examining how DPN may influence 
postural stability in people with BPPVDM are essential.  
4.8 Conclusion 
 
Fall prevention is a major focus of the care provided to people with diabetes. This study 
showed that people with type 2 diabetes and concurrent BPPV had significantly higher sway on 
compliant surfaces, vision deprived environments, and in situations with a narrow base of 
support. Information from this study is pertinent to clinicians working with people with diabetes 
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to identify daily life activities that could increase risk of falls, and to make patients aware of their 































Chapter 5 Preface 
 
 Diabetes and benign paroxysmal positional vertigo independently affect mobility and 
increase postural sway. In Chapter 5, we examined the functional status of people with 
BPPV+DM compared to those with BPV only, at baseline and after resolution of vertigo.  
Chapter 5 includes the combined results of Aim 1 and 3. The main objective of Aim 1 was to 
examine if the combined effect of BPPV and diabetes increased symptom severity, functional 
mobility deficits and postural sway prior to treatment, compared to people with BPPV only. Our 
hypotheses were that people with BPPV+DM would present with greater symptom severity, have 
higher mobility deficits and higher postural sway compared to people with BPPV only. The main 
objective of Aim 3 was to examine symptom severity, mobility and balance after resolution of 
vertigo; as well as the number of treament maneuvers required for resolution of vertigo, in 
people with BPPV+DM compared to those with BPPV only. Our hypotheses were that following 
treatment, people with BPPV+DM would continue to have more symptoms, and higher mobility 
and balance deficits and would require more repositioning maneuvers for symptom resolution 
compared to people with BPPV only. 
 Results of this study showed that at baseline, there were no differences in symptom 
severity or mobility deficits between people with BPPV and those with BPPV+DM. People with 
BPPV+DM had higher range and velocity of sway in tandem stance at baseline, compared to 
those with BPPV only. After resolution of symptoms, there were no differences between the 
groups in symptom severity, mobility or postural sway. The repositioning maneuver was 
effective in both groups, and people with BPPV+DM did not require additional treatment 








The Influence of Type 2 Diabetes on Symptom Presentation and Response to 























Background and Purpose: Type 2 diabetes affects the otolith organs of the vestibular system 
and the prevalence of benign paroxysmal positional vertigo (BPPV) is higher in people with 
diabetes. The combined effect of BPPV and type 2 diabetes (BPPV+DM) on symptom 
presentation, mobility, and balance, and the response to canalith repositioning maneuvers (CRM) 
is unknown. In this prospective study, we compared symptom severity, mobility and postural 
sway before and after treatment, as well as the number of treatment maneuvers needed for 
resolution of vertigo, in people with BPPV and BPPV+DM.  
Methods: Fifty participants completed the study in two groups, people with BPPV (n=34) and 
with BPPV+DM (n=16). The Dizziness Handicap Inventory (DHI) and Functional Gait 
Assessment (FGA) examined symptom severity and mobility, and an accelerometer examined 
postural sway in five different conditions, before and after the CRM. We compared the number 
of maneuvers required for resolution of vertigo, between groups.  
Results: At baseline, there was no difference in DHI scores (p=0.52) or FGA scores (p=0.28) 
between the BPPV and BPPV+DM groups, however there were significant differences in range, 
and peak velocity of sway in the anteroposterior and mediolateral directions, seen in tandem 
standing. After resolution of vertigo, both the DHI and FGA score showed a main effect of time 
(p<0.001), there was no effect of group (p=0.28; p=0.08), and no interaction between group and 
time (p=0.59; p=0.14). After symptom resolution, significant change was seen in postural sway 
in the mediolateral direction in people with BPPV+DM in the tandem stance position. There 
were no differences in the number of maneuvers needed between the two groups (p=0.37).  
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Conclusions:  People with BPPV and BPPV+DM have significant difficulty with mobility and 
function when symptomatic with vertigo; however, they both respond well to treatment 
maneuvers. Early identification of BPPV in people with diabetes, as well as prompt treatment 




















Type 2 diabetes (T2D) currently affects 29.1 million people in the United States,
1
 and is 
projected to affect 1 in 3 people by the year 2050.
2
 Diabetes causes microvascular complications 
such as peripheral neuropathy and retinopathy, which increase the risk of falls.
24, 26, 121
 Vestibular 
dysfunction is being recognized as a complication of T2D, and has been reported to be 70% 
higher in people with T2D, compared to age matched controls.
7
 In people with diabetes, 
vestibular dysfunction, and complaints of dizziness, the risk of falls is two times higher after 
accounting for peripheral neuropathy and retinopathy.
8
  
  Increasing evidence is showing both central and peripheral vestibular dysfunction in type 
1 and 2 diabetes.
9, 10, 35, 39, 41, 123, 151
 Metabolic stress due to hyperglycemia has been shown to 
cause loss of type 1 hair cells in the saccule
35
 and demyelination of the vestibulocochlear nerve,
10
 
in experimentally induced diabetic animal models; as well as peripheral vestibular organ 
dysfunction, of both the otolith organs and semicircular canals 
123, 124
 in clinical studies. One 
common vestibular condition, benign paroxysmal positional vertigo (BPPV) is prevalent and 
recurrent in people with type 2 diabetes.
43, 45
 One reason for the detachment of the otoconia is 
underlying degeneration of the otolith organs.
88, 94
 Posterior canal BPPV canalithiasis is the most 
common variant of BPPV, seen when otoconia fragments detach from the utricle and saccule and 
enter the posterior semicircular canal causing  movement of the endolymph, even after head 
movements have ceased.
67, 152, 153
 BPPV causes a position dependent vertigo and nystagmus, and 
is associated with loss of balance and frequent falls.
154-156
  Due to vertigo, individuals with BPPV 





  Fortunately, the canalith repositioning maneuver (CRM) is very effective in 
treating posterior canal BPPV.
51, 89, 90
  
 Presently, we do not have a clear understanding of how T2D may affect the clinical 
presentation of people with BPPV when they are symptomatic, or the efficacy of the CRM to 
resolve BPPV symptoms, in people with diabetes. The main objectives of this study were to 
compare symptom severity, mobility and postural sway in people with BPPV to those with both 
BPPV and type 2 diabetes (BPPV+DM) when symptomatic, and after the resolution of vertigo 
with the CRM. Our hypotheses were that: People with BPPV+DM would have 1) higher 
symptom severity measured by the Dizziness Handicap Inventory (DHI), 2) impaired functional 
mobility measured by the Functional Gait Assessment (FGA), and 3) higher postural sway when 
symptomatic with vertigo, compared to people with BPPV only. After the resolution of vertigo 
following CRM, our hypotheses were that people with BPPV+DM would continue to have 4) 
higher symptom severity, 5) greater impairments in functional mobility, 6) and higher postural 
sway. Because the prevalence and recurrence of BPPV is higher in the presence of T2D, we also 
hypothesized that 7) people with BPPV+DM would require more treatments with the CRM for 
symptom resolution compared to those with BPPV only.  
 As the population ages, the prevalence of both BPPV and T2D is predicted to increase. 
Clinicians will encounter both disease conditions frequently during the evaluation and treatment 
of their patients. The findings of this study would provide knowledge about how the presence of 
diabetes in a person with BPPV may affect their function and prognosis for recovery after 
treatment.    




5.3.1 Study Design 
This was a single center, prospective study with a sample of convenience, which included 
two groups of participants, those with BPPV and with BPPV+DM. In this single-blinded study, 
the primary investigator (LD) was blinded to the diabetes status of participants during both data 
collection time points. The Human Subjects Committee at the University of Kansas Medical 
Center approved the research protocol. Each individual provided institutionally approved written 
informed consent prior to participation in the study.   
5.3.2 Participants 
Individuals between 40 and 80 years with a diagnosis of unilateral posterior canal BPPV 
canalithiasis, as determined by a physician and confirmed by a physical therapist, were allocated 
to two groups, based on whether or not they had type 2 diabetes: BPPV and BPPV+DM.  
Participants were recruited through physician referral from the University of Kansas Medical 
Center neuro-otology clinic, as well as internal medicine, and family medicine clinics in the area.  
The diagnosis of posterior canal BPPV was based on the presence of torsional up beating 
nystagmus in the Dix-Hallpike position with a brief latency, nystagmus lasting less than 60 
seconds, which reversed upon sitting, with associated complaints of vertigo, 
67
 using 
videonystagmography (Micromedical, Visual Eyes 2002). Participants were excluded if they 
presented with any of the following: (1) history of neurological disease including stroke, multiple 
sclerosis, Parkinson’s disease, intracranial tumor, (2) history of Meniere’s disease, (3) received 
chemotherapy or ototoxic and/or neurotoxic medications, (4) traumatic head injury, (5) BMI 
greater than 45kg/m
2
, (6) musculoskeletal or integumentary conditions that would impair 
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balance. In addition, participants were excluded if videonystagmography revealed anterior or 
lateral canal BPPV canalithiasis, cupulolithiasis in any canal, or bilateral BPPV.  
After the resolution of symptoms, a detailed medical history, list of medications, the 
presence or absence of diabetes, hypertension and BMI were collected from the electronic health 
records. In addition, glycosylated hemoglobin (HbA1c) was tested via a disposable finger stick 
testing kit (Metrika A1cNow
+ 
Bayer, Tarrytown NY). Participants were classified as BPPV+DM 
if they had a physician diagnosis of T2D in their health records. Participants were screened for 
the presence of diabetic peripheral neuropathy (DPN), using the Michigan Neuropathy Screening 
Instrument (MNSI), which has a questionnaire and physical exam components.
55
 Participants 
were classified as having DPN if their physical exam score was ≥ 2.0.
69
  
5.3.3 Study Procedures  
 Once inclusion/ exclusion criteria and the diagnosis of unilateral posterior canal BPPV 
was confirmed, informed consent was obtained from participants and baseline outcome measures 
were collected.  
After collection of baseline outcome measures, all participants received treatment for 
posterior canal BPPV, with the canalith repositioning maneuver (CRM).
67
  All participants 
received restrictions to follow for 48 hours, including no bending, no looking overhead, and no 
sleeping on the affected side.  
Participants returned for follow up between 7 to10 days of the initial evaluation, and the 
Dix-Hallpike was repeated using videonystagmography, to test if the BPPV had resolved. If 
participants had no nystagmus or vertigo with Dix-Hallpike testing, they were considered 
symptom-free, and post-treatment outcome measures were collected. If nystagmus and vertigo 
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persisted, they received another CRM, and were scheduled to follow up in 7 to10 days, until 
resolution of symptoms. Once symptoms were resolved, the assessor was un-blinded with regard 
to diabetes status, at which time the MNSI physical was completed and HbA1c level was 
collected (Refer to Figure 1).  
 
Figure 1: Study sequence flow sheet. DHI- Dizziness Handicap Inventory, FGA- Functional Gait 
Assessment, CRM- canalith repositioning maneuver, MNSI- Michigan neuropathy screening instrument, 
HbA1c- glycosylated hemoglobin level 
5.3.4 Outcomes 
 The following outcome measures were collected at baseline and after resolution of 
vertigo  
Dizziness Handicap Inventory (DHI): This is a standardized measure of self-report activity 
limitation and participation restriction due to either dizziness or unsteadiness 
55
. It is a 25-item 
questionnaire with three subscales: functional, emotional and physical. It has a high test-retest 
reliability, good internal consistency, 
55





 with an 18-point change on the DHI considered clinically meaningful.
55
 A DHI 
total score of 0-14 indicates no activity limitation and participation restriction; 16-26 as mild 
activity limitation, 28-44 as moderate and a total score of 46 or greater as severe activity 
limitation.
55
   
Functional Gait Assessment (FGA): The FGA is a 10-item functional mobility test,
64, 189
 that is 
scored on a four point ordinal scale (0-3) with a higher score indicating greater control during 
functional mobility. The FGA has moderate to strong correlations with other standard tests of 
balance.
64
 A cut-off score of 22/30 on the FGA provides optimum validity for classifying fall 
risk in older adults.
64
  
Postural sway: Participants were assessed in quiet standing in five conditions: (1) standing on a 
firm surface with eyes open; (2) standing on a firm surface with eyes closed, (3) standing on a 
foam pad with eyes open, (4) standing on a foam pad with eyes closed, and (5) tandem standing 
with eyes open on a firm surface. Details of postural sway assessment are described in detail in 
Chapter 4. The following variables were analyzed: 1) Range (cm/s
2
), 2) peak velocity (cm/s), and 
3) root mean square (RMS). All sway variables were examined in the anteroposterior (AP) and 
mediolateral (ML) directions. 
Number of treatment maneuvers:  Every repositioning maneuver performed was counted, with 
usually one repositioning maneuver done per session. In some participants, who were able to 
tolerate the procedure, the Dix-Hallpike was repeated in the same session and if the person was 
symptomatic, they received another CRM. No more than two CRM were done in one treatment 
session. All maneuvers that a participant required to achieve complete resolution of symptoms 
were added, to get a total count. 
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5.4 Statistical Analysis  
 
 Descriptive statistics (mean, standard deviation, %) were used to present participant 
demographics in each group. Differences in demographics between groups were examined using 
ANOVA and for significant differences, Tukey’s pairwise comparisons were completed. After 
examining data for normality and homogeneity of variance, ANOVA was used to compare 
baseline DHI, and FGA scores between groups, and a general linear mixed model was used to 
examine postural sway measures before treatment between the two groups. Repeated measures 
ANOVA were used to examine change in DHI and FGA scores with treatment between groups. 
Change in range-AP, range-ML, PV-AP, PV-ML, RMS-AP and RMS-ML were examined using 
a general linear mixed model, with the change score on each condition entered as within subject 
factor, while group as between subject factor. The condition by group interaction was used to 
evaluate the group differences within conditions. For a significant model, we performed post hoc 
comparisons using Tukey’s least significant difference for multiple comparisons. We compared 
number of treatment maneuvers required between groups using Mann-Whitney U tests. Data was 
analyzed using SPSS 20.0 (SPSS, Inc., Chicago, IL) with significance level set at 0.05.  
5.5 Results    
 
The screening and enrollment numbers for this study are presented in Figure 2. Two 
participants with BPPV dropped out from initial evaluation to final collection of outcome 
measures due to due to transportation difficulties. One participant with BPPV+DM dropped out 
because of shoulder pain that interfered with correct CRM technique. All three participants were 
excluded from the study, including baseline analysis. Due to equipment malfunction, we were 




Figure 1: Participant enrollment chart. BPPV- benign paroxysmal positional vertigo, BPPV+DM- 
BPPV and type 2 diabetes 
Participant demographics are presented in Table 1, as expected, significant differences 
were seen in HbA1c (p<0.001) and BMI (p=0.002) between the groups.  
Table 1: Participant Characteristics  
 BPPV (n=34) BPPV+DM (n=16) p 
Age (years) 58.85 ± 10.65 62 ± 7.8 p=0.29 
Gender (Female/ male) 29/5 10/6  
HbA1c (unit-%) 5.66 ± 0.41 6.93 ± 1.4 p<0.001 
BMI (kg/m
2 
) 29.56 ± 7.6 36.27 ± 4.4 p=0.002 
Peripheral neuropathy 6 (17%) 8 (50%)  
HbA1c- glycosylated hemoglobin, BMI- body mass index, BPPV-benign paroxysmal positional vertigo, 




Dizziness Handicap Inventory: 
At baseline, there was no difference in DHI scores between groups (p=0.52). The DHI 
score changed significantly (pre to post treatment), with a main effect of time (p<0.001). There 
was no effect of group (p=0.28), and no interaction between group and time (p=0.59).  Figure 3a 
shows DHI scores before and after treatment in both groups.  
 
Figure 3: Change in 3a) DHI and 3b) FGA scores in both groups before and after 
treatment DHI- Dizziness Handicap Inventory, FGA- Functional Gait Assessment, BPPV- benign 
paroxysmal positional vertigo, BPPV+DM- BPPV and type 2 diabetes. 
 
Functional Gait Assessment:  
At baseline, there was no difference in FGA scores between groups (p=0.29). FGA scores 
changed significantly with treatment showing a main effect of time (p<0.001). There was no 
effect of group (p=0.08), and no interaction between group and time (p=0.14). Figure 3b shows 




Postural sway variables: 
 Results of postural sway comparison at baseline are presented in another manuscript and 
summarized here (Chapter 4, in review). 
Range of acceleration:  
At baseline, the postural sway variables of range of acceleration (AP and ML direction) 
and peak velocity (AP and ML direction) showed a significant interaction between group and 
condition. Post hoc analysis revealed that the BPPV+DM group had higher sway in condition 5, 
tandem stance, compared to the BPPV group (Figure 3). No effect of condition, group, or 
interaction between group and condition was noted for RMS at baseline.   
Analysis of data following the treatment (change scores) revealed no effect of condition, 
group, or interaction between group and condition for any of the AP postural sway change scores 
(range, velocity, or RMS). 
Change scores for range-ML showed a main effect of condition (p=0.002), and 
interaction between group and condition (p=0.003). The BPPV+DM group showed significant 




Figure 3: Means and standard errors of range in the anteroposterior (AP) and mediolateral 
(ML) direction in the two groups across the five testing conditions, before and after 
treatment. BPPV-benign paroxysmal positional vertigo, BPPV+DM- BPPV and concurrent type 2 
diabetes 
Change scores for PV-ML showed a significant main effect of condition (p=0.001), group 
(p=0.03), and interaction between group and condition (p=0.003). The BPPV+DM group showed 




Figure 4: Means and standard errors of peak velocity in the anteroposterior (AP) and 
mediolateral (ML) direction in the two groups across the five testing conditions, before and 
after treatment. BPPV-benign paroxysmal positional vertigo, BPPV+DM- BPPV and type 2 diabetes 
                             
Change score for RMS showed no effect of condition, group, or interaction between 
group and condition in the AP or ML directions.  
 
Treatment Maneuvers:  
 In the BPPV group, the average number of CRM performed was 1.8 ± 1.4, with a range 
between 1 and 7. In the BPPV+DM group, the average number of CRM performed were 2.0 ± 





        The main purpose of this study was to examine if the presence of diabetes increased 
BPPV symptoms, mobility and balance deficits or changed the efficacy of CRM treatments. 
Because T2D affects the neural and muscular structures, and the otolith organs directly, we 
hypothesized that people with BPPV and T2D would have more symptoms and mobility deficits 
when symptomatic, as well as after CRM treatment. Results of the study showed that diabetes 
did not increase symptom severity or decrease functional mobility before or after treatment. 
Both, people with BPPV and those with BPPV and T2D, improved significantly after successful 
resolution of the vertigo with CRM; and people with BPPV+DM did not require additional 
treatment maneuvers for symptom resolution when compared to those with BPPV only.   
People with BPPV and BPPV+DM showed significant improvement in the Dizziness 
Handicap Inventory scores after the treatment maneuver. Both groups improved by more than 18 
points, which is a clinically meaningful change,
55
 showing that both people with BPPV and those 
with BPPV+DM benefitted significantly from treatment. However, we found that residual 
symptoms persisted in both groups, at levels that would indicate mild restriction of physical 
activity due to dizziness.
55
 Results of our study are similar to others that have shown significant 
improvement in DHI scores after resolution of vertigo in people with BPPV,
190




Functional mobility based on the Functional Gait Assessment improved significantly 
after treatment in both the BPPV and BPPV+DM groups, showing lower risk of falls.
64
 
Although, we could not find studies that have examined the FGA after treatment of BPPV, a 






     As we have previously reported, people with BPPV and BPPV+DM had higher postural 
sway values before treatment, particularly in conditions with altered proprioception, vision, or 
both; namely when standing on foam with eyes closed. These findings are similar to those of 
other researchers who have examined balance in people with BPPV.
149, 154, 158, 193
 After 
successful resolution of vertigo, all participants showed a decrease in postural sway measures 
that was particularly evident in condition four, standing on foam with eyes closed. Results of our 
study are similar to Celebisoy et al
157
 who showed that sway velocity was higher when standing 
on foam with eyes closed, compared to healthy controls, and a significant reduction in sway was 
observed after the canalith repositioning maneuver, approaching control sway. Our study showed 
that people with BPPV+DM made significant improvement in postural sway after the CRM; this 
improvement was seen in the mediolateral direction, when standing on foam with eyes closed as 
well as in tandem stance (condition 4 and 5). There were no differences between the groups in 
sway measures in the anteroposterior directions. Although we did not have a comparison with a 
healthy age matched control group for this study, the results of Chapter 4, show that neither the  
BPPV or BPPV+DM groups achieved levels of sway post treatment noted in the control group of 
our previous study, when standing on foam with eyes closed and tandem standing. Other 
researchers have found that postural sway did not improve completely immediately after the 
CRM in people with BPPV,
149, 154




Based on the results of this study, we can conclude that people with BPPV (with or 
without diabetes) have significant deficits in daily activity, functional mobility and balance, and 
they respond well to treatment with the repositioning maneuver. This information underscores 
the importance of making an accurate vestibular diagnosis in people with T2D who present with 
101 
 
dizziness. Fife et al
195
 found that it took 92 weeks for people with BPPV to obtain successful 
treatment of their vertigo, and once diagnosed 75% recovered from their symptoms in just one 
session. Oghalai et al. reported that 9% of adults with multiple comorbidities like T2D and 
hypertension go undiagnosed, with higher rates of falls and poor quality of life.
66
  
Another important result of this study is that although people with BPPVDM respond 
well to treatment maneuvers, just like people with BPPV, they may require additional gait and 





 The main limitation of this study is the small sample size, particularly in the BPPV+DM 
group. This is likely due in part to our strict inclusion criteria, which did allow us to focus our 
attention to people with BPPV specifically in the posterior canal, of the canalithiasis variant. 
Participants in this study were from a wide age range, and age is known to affect balance and 
mobility. However the difference in age between groups was not statistically significant. Our 
study was conducted at a tertiary care center, where a large majority of our participants 
particularly in the BPPV group, had a history of recurrent episodes of BPPV, and hence, they 
may have been more complex and difficult to treat than people with BPPV recruited from the 
general community. We did not have a control group to compare postural sway measures with 
our participants after treatment, hence we could not assess if the postural sway measures returned 
to normal sway levels.  




 People with both BPPV and type 2 diabetes have functional deficits in daily activity, 
mobility, and balance similar to those seen in people with BPPV. Fortunately, these deficits 















































6.1 Summary of Findings 
 
 This body of presented work extends the known impact of the complications of type 2 
diabetes on the proprioceptive system and visual system, to another sensory system, the 
vestibular system. In this body of work, we explored the impact of vestibular dysfunction due to 
diabetes on a person’s functional abilities and balance. Overall, our findings validate the results 
of other studies that have shown vestibular dysfunction due to diabetes. This is the first body of 
work to look at a specific vestibular condition, benign paroxysmal positional vertigo (BPPV), 
and the effect of diabetes in this patient population. The findings of this work have implications 
for the evaluation and treatment of individuals with type 2 diabetes and concurrent BPPV in 
clinical settings. 
Chapter 2 Retrospective Data suggests that the Higher Prevalence of Benign Paroxysmal 
Positional Vertigo in Individuals with Type 2 Diabetes is Mediated by Hypertension. 
 The purpose of this study was to identify if diabetes increased the prevalence of specific 
vestibular conditions. Using a retrospective study design, we examined the charts of 3933 
individuals, with results showing that the frequency of BPPV was significantly higher in people 
with diabetes. This study validated the results of one other study,
43
 but was instrumental in 
showing how hypertension was the mediator in the relationship between diabetes and BPPV. 
This study contributes to science by identifying potential pathological mechanisms that may 
influence the prevalence of BPPV. Understanding underlying mechanisms can help in the 
development of new treatment strategies that may help to delay or prevent BPPV. 
Chapter 3: Both Diabetes and Benign Paroxysmal Positional Vertigo affect Otolith Function 
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 While many studies have shown impaired otolith function in people with BPPV, none of 
them had evaluated if their participants with BPPV had comorbidities like diabetes, which could 
have affected otolith function. A few, recent studies, have examined otolith function in people 
with T2D,
123, 124
 but our study is the first to examine and compare otolith function in people with 
BPPV+DM to controls, people with T2D, and people with BPPV. Results of this work shows 
that saccule dysfunction was higher in people with T2D, BPPV and BPPV+DM compared to 
controls, with prolonged saccule latencies associated with higher HbA1c levels. In people with 
BPPV+DM, we did not see a distinct cumulative effect of BPPV and T2D on the otolith organs. 
Chapter 4: Postural Sway is Significantly Higher in Individuals with Type 2 Diabetes and 
Concurrent Benign Paroxysmal Positional Vertigo  
 The purpose of this study was to extend the findings of Chapter 3 to look at postural 
control in individuals with BPPV+DM. Because otolith organ dysfunction is associated with 
postural instability, our next step was to examine postural sway in people with BPPV+DM and 
compare the findings with people with BPPV, T2D and controls. In Chapter 4, we examined 
postural sway using an accelerometer, and found that postural sway was significantly higher in 
people with BPPV+DM compared to people with T2D and healthy controls, particularly when 
standing on a compliant surface with eyes closed and in tandem stance. This study makes a 
significant contribution to the existing body of literature by showing that during everyday 
activities, there are certain positions in which people with BPPV+DM may feel unstable, which 
could increase their risk of falling.   
Chapter 5: The Impact of Type 2 Diabetes on Symptom Presentation and Response to Treatment 
in Individuals with Benign Paroxysmal Positional Vertigo  
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 Based on the preceding chapters, we found impairments in otolith function and postural 
control in people with BPPV+DM, which could potentially affect daily function, mobility and 
recovery after treatment with the canalith repositioning maneuver. In this study, we compared 
symptom severity, functional mobility and postural control in people with BPPV+DM to those 
with BPPV only. We examined if diabetes influenced the number of repositioning maneuvers 
required for resolution of vertigo, as well as function after treatment to evaluate if people with 
BPPVDM recovered to the same extent as those with BPPV only. Results of this study showed 
that people with BPPV regardless of their diabetes status, improved significantly with 
repositioning maneuvers in all aspects of daily life. People with BPPV+DM did not require 
additional maneuvers and there were no differences between the groups on measures of 
handicap, mobility, or balance after resolution of symptoms. Results of this study underscore the 
importance of early diagnosis and effective treatment of people with BPPV+DM. 
6.2 Potential Mechanisms by which type 2 diabetes affects gait and balance- what is the 
significance of the vestibular system? 
 
Balance is a motor skill that emerges from the interaction of multiple sensory systems to 
meet functional goals. The proprioceptive, visual, and vestibular systems, work together to 
provide the body with optimal feedback to ensure appropriate motor planning and execution. In 
people with diabetes and BPPV, all three sensory systems may be affected, thereby, affecting 
mobility and function. 
Peripheral neuropathy due to diabetes 
 Diabetic peripheral neuropathy (DPN) affects up to two-thirds of individuals with 
diabetes, and is characterized by pain, paresthesia and sensory loss.
16
 Postural sway is higher in 
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people with DPN who have a longer duration of diabetes, and poorly controlled hyperglycemia. 
22, 23
 The greatest decrease in postural stability in individuals with DPN, is seen with eyes closed, 
showing a reliance on vision to compensate for sensory deficits.
6
 People with DPN fall more 
often and the cause of the recurrent falls are decreased vibration sense and loss of pressure 
sensitivity due to DPN.
24
 Because of decreased proprioceptive feedback during walking, older 
adults with diabetes walk slower and have greater stride variability, increasing the risk of falls.
25
 
Although aerobic exercise has been shown to increase intra-epidermal nerve fiber branching in 
people with DPN,
73, 196
 currently, there are no therapeutic interventions that can reverse DPN.  
Diabetic Retinopathy 
 In the United States, about 40% of individuals with type 2 diabetes and 86% with type 1 
diabetes develop retinopathy.
17
 There are strong associations between diabetic retinopathy, the 




Vestibulopathy due to diabetes 
 The odds of developing vestibular dysfunction are 70% higher among adults with 
diabetes compared to those without diabetes,
7
 especially in people with a longer duration of 
diabetes, higher serum HbA1C levels (≥ 7.0%),
8
 and in those people who have other diabetes-
related complications like peripheral neuropathy and retinopathy.
8
 In people with diabetes, the 
odds of falling are two times higher, even after taking retinopathy and neuropathy into account.
8
  
 Based on the review of existing literature, diabetes can impair gait and balance by 
affecting all three sensory systems: proprioception, vision, and vestibular. The results of our 
study showed that people with BPPV+DM had a higher frequency of abnormal saccule responses 
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compared to healthy age matched controls. However, abnormal VEMP responses in the 
BPPV+DM group were not different from the BPPV only or the T2D only groups. Given this 
information, we would have expected that postural sway would be similar in people with T2D, 
BPPV, and BPPV+DM. However, we found significantly increased postural sway in people with 
BPPV+DM, particularly when standing on foam with eyes closed and tandem stance. In 
conditions of daily life, where vision and somatosensation are available and dependable sources 
of sensory information, people with BPPV+DM perform well. In compromised situations like 
compliant or uneven surfaces and with a narrow base of support, they had higher sway compared 
to all other groups. It appears that factors other than otolith dysfunction may contribute to this 
increased sway; peripheral neuropathy, which was seen in 50% of people with BPPVDM, could 
be one possible factor. In addition, other factors like weakness, decreased endurance due to 
sedentary lifestyles, and obesity may have contributed to increased sway. We did not examine 
these factors; however, it would be interesting to examine the relative contributions of these 
factors, mainly because they are all modifiable with diet, exercise, and education.  
People with BPPV and diabetes may be unable to reweight their sensory systems to meet 
the demands of daily life. Participating in walking programs may be difficult for people with 
BPPV+DM, especially if they have to walk outdoors and on uneven sidewalks. Identifying and 
treating the BPPV is essential, but even after successful treatment of vertigo, balance deficits 
persist. Balance training may be necessary to teach people how to use their available sensory 
capabilities more effectively. Even if the function of the peripheral vestibular organs does not 
improve, we need to identify if we can improve balance by influencing central mechanisms. This 
study provides the framework by which we can move ahead to identify the role of vestibular 
rehabilitation. We need to develop exercises that target the otolith organs, to benefit all people 
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with BPPV. We need to identify outcome measures that are sensitive to deficits and change in 
people with BPPV.  We need to identify exercises that may help to prevent BPPV and prescribe 
them efficiently to delay recurrences. We need to disseminate the information gleaned from this 
body of work to physicians and other health care providers to promote early diagnosis and 
treatment of BPPV. In addition, education regarding the risk of potential falls, particularly in 
professionals such as painters, and construction workers, where people are working at heights, 
will help to reduce falls. 
6.3 Limitations 
6.3.1 Setting of Study 
All of the testing for this study was completed in the Otolaryngology-Head and Neck 
Surgery clinic at the University of Kansas Medical Center. We had a quiet room to conduct the 
examinations and posture testing and a soundproof room to complete the VEMP testing. 
However, KUMC is a tertiary care center; hence, a majority of the participants in this study had 
recurrent episodes of BPPV. This may have influenced recovery patterns since people with 
recurrent episodes of BPPV are more difficult to treat.  
6.3.2 Participant Characteristics and Sample Size 
 The participants with BPPV, both with and without diabetes, who were recruited for this 
study, were in good health. We did not have a variety of participants with poor and uncontrolled 
T2D; hence, this study may not be representative of the diabetic population at large. In addition, 
majority of our T2D control group participants were employees from the medical center. They 
all had well controlled diabetes and we did not see a variety of participants with poor or 
uncontrolled blood glucose levels. 
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Another limitation of our sample was the modest sample size per group. Although, we 
had adequate participants in the BPPV group, we could not recruit enough participants in our 
BPPV+DM group, despite our extensive recruitment efforts. We lost three subjects to follow-up, 
which is a small number, but affected our total subjects analyzed. Due to the small sample, we 
could not analyze mobility and function based on the presence of DPN, even though we had 
completed the MNSI on all participants.  
Our participants were 40-80 years of age; hence, they did have other comorbidities like 
osteoarthritis, osteoporosis, joint arthroplasty, mild visual impairments, migraine, and other such 
conditions. We included them in the study if they were ambulating independently without 
physical impairment. In addition, all participants took a variety of medications, and those with 
BPPV+DM were taking ant-diabetic medications and/or exogenous insulin. We collected the list 
of comorbidities and medications, but did not control for them in the study. 
6.3.3 Study Design:  
Our study was designed to confirm the diagnosis of BPPV in the participant and collect 
outcome measures immediately after the diagnosis was confirmed. Likewise, at the end of the 
study, if VNG did not show torsional nystagmus, the BPPV was considered resolved and 
outcomes were collected immediately. Because of this design, several participants were unsure 
when answering the Dizziness Handicap Inventory after treatment, as they did not have enough 
time to evaluate how much daily activity still bothered them.  
We used the MNSI to make a diagnosis of diabetic peripheral neuropathy; however, this 
test is not the gold standard for diagnosing peripheral neuropathy.  
6.3.4 Tests and Measures: 
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The VEMP is a sensitive test of otolith function, however, evoked potential tests are 
responses derived from muscle contraction. Our equipment did not have the electromyography 
feature built into the machine. Hence, we could not control for baseline variations of muscle 
activity during the oVEMP or account for increased muscle activity, which directly affects the 
cVEMP response. We used the blood pressure manometer technique, which is a validated 
technique to control for contraction of the sternocleidomastoid.
142
 Since we could not control for 
variations in amplitude of oVEMP, results related to amplitude of the oVEMP have to be viewed 
with caution. 
Studies in people with unilateral BPPV have shown that both ears have abnormal VEMP 
responses, which persist after successful repositioning,
148
 indicating a permanent change in 
function of the saccule. The subjective visual vertical (SVV) is a test that has been shown to be 
useful to identify utricle dysfunction in people with BPPV.
197
 Responsiveness of the SVV in 
people with BPPV has not been examined, it may be a useful test to show if utricle function 
improves after the canalith repositioning maneuver. 
The Functional Gait Assessment (FGA), used in this study to assess mobility has been 
validated in the vestibular population in people with unilateral and bilateral vestibular 
hypofunction. However, people with BPPV are high functioning and not all items of the FGA are 
difficult for them to perform. Hence, the overall score on the FGA may not be sensitive enough 
to detect their deficits. Analyzing individual items on the FGA, i.e. looking at change in gait 
speed or specifically examining items that depend heavily on the vestibular system, like walking 
with eyes closed, may be more sensitive to deficits and change with treatment in this patient 
population, compared to the total score.  
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We examined accelerometry before and after treatment in people with BPPV and 
BPPV+DM, however, we did not compare accelerometry results after treatment to a control 
group, in the same age range. Having a comparison of this nature, would be particularly useful at 
the end of the treatment to examine if people with BPPV and BPPV+DM returned to the same 
baseline level as healthy, age matched controls.  
6.4 Future Directions 
 
 This body of work addresses several key areas showing the effect of type 2 diabetes on 
the vestibular system and the impact it has on daily life. The future directions proposed arise 
from questions that remain unanswered. 
6.4.1 Comprehensive Assessment of the Vestibular System: 
Vestibular Tests: 
In this study, we focused our attention on the otolith organs because our patient 
population had an identified otolith problem. However, they could also have had semicircular 
canal involvement as well as central vestibular structures involved. Studies in people with type 1 




 vestibular structures. 
Hence, future studies need to extend the examination of people with BPPV to include the 
semicircular canal. Including the caloric test and examination of the vestibular-ocular reflex, 
which includes the vestibular head thrust test, and the dynamic visual acuity test, will provide 
information about the semicircular canals and their functional status. Using 
videonystagmography to examine nystagmus with position changes, the optokinetic reflex, as 
well as rotary chair tests, will allow for a comprehensive examination of central and peripheral 
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vestibular structures. We need to examine differences in all these measures in people with BPPV 
with and without T2D, before and change after treatment.  
Future studies need to examine the VEMP immediately after treatment as well as 12 
weeks after treatment, which is the time period at which balance improves in people with BPPV. 
We need to see if there are improvements in balance in people with BPPV+DM, and if there are 
changes in the VEMP, and the time point at which the changes are noted. In addition, examining 
the utricle using the subjective visual vertical test would be a good addition to assess otolith 
function. 
6.4.2 Physical Therapy tests and measures of vestibular function: 
Future studies are needed to identify tests and measures that are sensitive to functional 
deficits and responsive to change, in people with BPPV. The Functional Gait Assessment was 
developed with additional items that challenged the vestibular system, because the Dynamic Gait 
Index had a ceiling effect in some vestibular patient populations. Although, we found that the 
FGA was sensitive to change after treatment, the total score was not able to reflect the activities 
that continued to be difficult after treatment. It is necessary to identify the specific items of the 
FGA that do not improve after the vertigo has resolved, so that they can be incorporated into 
exercise programs for individuals with BPPV+DM, to improve treatment outcomes.  
Future studies that examine fall risk in people with BPPVDM are essential. People with 
diabetes are known to have a higher fall risk, become recurrent fallers, and sustain more severe 
injuries compared to those without diabetes. In our study, we did not include measures to assess 
falls. However, in people with T2D, with diabetic complications like neuropathy and retinopathy, 
having the additional burden of vestibular dysfunction could increase risk of falls significantly. 
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Examining fall risk will help in the development of education tools and fall prevention programs 
that could benefit this patient population tremendously. 
6.4.3 Management of People with BPPV: 
This study demonstrates that the canalith repositioning maneuver was very effective for 
the management of BPPV and improved the quality of life in all individuals treated. This 
underscores the importance of making an early and accurate diagnosis of the canal involved, so 
that the appropriate treatment maneuver can be performed. It is essential to educate health care 
professionals who work with people with diabetes regarding the prevalence of BPPV. Asking 
only a few pointed questions about the dizziness, can help identify BPPV so that an appropriate 
referral can be made for treatment. Recent studies continue to show that the Dix-Hallpike test, 
which is the gold standard to diagnose BPPV, is performed in only 3.9% of people who come to 
the emergency department with complaints of dizziness.
198
 To disseminate the information to 
rural areas with limited number of vestibular therapists, future studies looking at tele-medicine as 
a viable option to diagnose and treat individuals with BPPV would be beneficial. 
Most importantly, we need to identify which balance exercises will benefit people with 
BPPV+DM. If we identify semicircular dysfunction, we need to explore the usefulness of gaze 
stability exercises, which is not part of a standard exercise prescription currently for people with 
diabetes. For otolith dysfunction, we need to develop exercises that target the otolith organs. 
Presently, balance exercises on compliant surfaces and with eyes closed are shown to improve 
balance. However, we need to examine which movements specifically stimulate the otolith 
organs, and the frequency and duration of exercise, which would make the most meaningful 
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change, so that we can include them in our exercise prescription. We need to examine change 
with standard exercises, and change with a more focused vestibular prescribed program. 
We need to examine the recurrence rate in people with BPPV+DM. We need to conduct 
longitudinal studies that look at the recurrence rates of BPPV in people with T2D as well as 
evaluate the benefit of preventative exercises so that we can effectively prescribe preventative 
exercises for people with BPPV+DM.   
6.4.4 Other Patient Populations: 
 Vestibular dysfunction is commonly seen in veterans who have returned from wars, after 
being exposed to either direct or indirect blast trauma. Evaluating the extent of damage to the 
vestibular organs in veterans, and examining the prevalence as well as recurrence of BPPV could 
provide valuable information on the pathophysiology of BPPV. As the veteran population ages, 
and they present with comorbidities like hypertension and diabetes, it is necessary to examine 
their symptom presentation, examine how vertigo affects their daily activities, and proactively 
evaluate what we can do to avoid falls and injury.  
6.5 Conclusion 
  
 This body of work provides evidence that vestibular dysfunction is a complication of type 
2 diabetes. The prevalence of BPPV is higher in people with type 2 diabetes, with the saccule 
more affected by diabetes compared to the utricle. Postural sway is higher in the presence of type 
2 diabetes and BPPV, especially in challenging conditions. However, the canalith repositioning 
maneuver was effective in treating vertigo and people with type 2 diabetes and concurrent 
BPPV, recovered just as well as those with BPPV without diabetes. Overall, our findings 
reinforce the importance of making an early and accurate diagnosis of BPPV in people with 
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coexisting comorbidities, so that they can be treated effectively. This study highlights the need 
for further research investigating physiological and functional factors, in patient populations that 
have vestibular dysfunction, like our veterans. It also emphasizes the need to develop focused 
exercise programs that will stimulate the otolith organs that are affected in people with both 
BPPV and T2D.  
6.6 Funding and Assistance 
 
 This project was supported by an institutional grant T32HD057850 from the Eunice 
Kennedy Shriver National Institute of Child Health & Human Development, and the Kansas 
Partners for Progress, which is sponsored by the Kansas Physical Therapy Association. REDCap 
at the University of Kansas Medical Center is supported by CTSA grant (CTSA Award # 
UL1TR000001) from NCRR and NCATS awarded to the University of Kansas Medical Center. 
We gratefully acknowledge Dr. Susan Whitney for her guidance and consultation. We also wish 
to thank Jennifer Proctor, for her assistance with participant recruitment and Christy Maddux for 
her assistance with the VEMP study. We would like to thank the physicians at the University of 
Kansas Internal Medicine and Family Medicine clinics for their assistance with participant 
recruitment. Finally, we wish to thank all the PhD students and Deidre Leist, DPT student for 








1. Center for Disease Control and Prevention: Diabetes Fact Sheet [web page]. CDC 2015. 
Accessed November 28, 2015. 
2. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 
2050 burden of diabetes in the US adult population: dynamic modeling of incidence, 
mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29. 
3. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. Apr 2013;36(4):1033-
1046. 
4. Cade WT. Diabetes-Related Microvascular and Macrovascular Diseases in the Physical 
Therapy Setting. Phys. Ther. November 2008 2008;88(11):1322-1335. 
5. Schwartz AV, Vittinghoff E, Sellmeyer DE, et al. Diabetes-related complications, 
glycemic control, and falls in older adults. Diabetes Care. Mar 2008;31(3):391-396. 
6. Simoneau GG, Ulbrecht JS, Derr JA, Becker MB, Cavanagh PR. Postural instability in 
patients with diabetic sensory neuropathy. Diabetes Care. Dec 1994;17(12):1411-1421. 
7. Agrawal Y, Carey JP, Della Santina CC, Schubert MC, Minor LB. Disorders of balance 
and vestibular function in US adults: data from the National Health and Nutrition 
Examination Survey, 2001-2004. Arch. Intern. Med. May 25 2009;169(10):938-944. 
8. Agrawal Y, Carey JP, Della Santina CC, Schubert MC, Minor LB. Diabetes, vestibular 
dysfunction, and falls: analyses from the National Health and Nutrition Examination 
Survey. Otol. Neurotol. Dec 2010;31(9):1445-1450. 
118 
 
9. Gawron W, Pospiech L, Orendorz-Fraczkowska K, Noczynska A. Are there any 
disturbances in vestibular organ of children and young adults with Type I diabetes? 
Diabetologia. May 2002;45(5):728-734. 
10. Myers SF. Myelin-sheath abnormalities in the vestibular nerves of chronically diabetic 
rats. Otolaryngol. Head Neck Surg. Nov 1998;119(5):432-438. 
11. Myers SF, Ross MD, Jokelainen P, Graham MD, McClatchey KD. Morphological 
evidence of vestibular pathology in long-term experimental diabetes mellitus. I. 
Microvascular changes. Acta Otolaryngol. Nov-Dec 1985;100(5-6):351-364. 
12. Proceedings of the American College of Endocrinology and American Diabetes 
Association Consensus Conference, Washington, DC, January 30-31, 2006. Endocr. 
Pract. Jul-Aug 2006;12 Suppl 3:3-111. 
13. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and 
the biochemical basis of diabetic complications. N. Engl. J. Med. May 19 
1988;318(20):1315-1321. 
14. Kinoshita JH, Nishimura C. The involvement of aldose reductase in diabetic 
complications. Diabetes Metab. Rev. Jun 1988;4(4):323-337. 
15. Malik RA, Tesfaye S, Thompson SD, et al. Endoneurial localisation of microvascular 
damage in human diabetic neuropathy. Diabetologia. May 1993;36(5):454-459. 
16. Pasnoor M, Dimachkie MM, Kluding P, Barohn RJ. Diabetic neuropathy part 1: 
overview and symmetric phenotypes. Neurol. Clin. May 2013;31(2):425-445. 
17. Kempen JH, O'Colmain BJ, Leske MC, et al. The prevalence of diabetic retinopathy 
among adults in the United States. Arch. Ophthalmol. Apr 2004;122(4):552-563. 
119 
 
18. Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin. 
Ophthalmol. Dec 1999;14(4):223-232. 
19. Speiser P, Gittelsohn AM, Patz A. Studies on diabetic retinopathy. 3. Influence of 
diabetes on intramural pericytes. Arch. Ophthalmol. Sep 1968;80(3):332-337. 
20. Miyamoto K, Ogura Y. Pathogenetic potential of leukocytes in diabetic retinopathy. 
Semin. Ophthalmol. Dec 1999;14(4):233-239. 
21. Miller JW, Adamis AP, Aiello LP. Vascular endothelial growth factor in ocular 
neovascularization and proliferative diabetic retinopathy. Diabetes Metab. Rev. Mar 
1997;13(1):37-50. 
22. Boucher P, Teasdale N, Courtemanche R, Bard C, Fleury M. Postural stability in diabetic 
polyneuropathy. Diabetes Care. May 1995;18(5):638-645. 
23. Corriveau H, Prince F, Hebert R, et al. Evaluation of postural stability in elderly with 
diabetic neuropathy. Diabetes Care. Aug 2000;23(8):1187-1191. 
24. Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher 
risk of falls: a prospective study. Diabetes Care. Oct 2002;25(10):1749-1754. 
25. Roman de Mettelinge T, Cambier D, Calders P, Van Den Noortgate N, Delbaere K. 
Understanding the relationship between type 2 diabetes mellitus and falls in older adults: 
a prospective cohort study. PLoS One. 2013;8(6):e67055. 
26. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ. Diabetes and risk of fracture: The Blue 
Mountains Eye Study. Diabetes Care. Jul 2001;24(7):1198-1203. 
27. Yau RK, Strotmeyer ES, Resnick HE, et al. Diabetes and risk of hospitalized fall injury 
among older adults. Diabetes Care. Dec 2013;36(12):3985-3991. 
120 
 
28. Napoli N, Strotmeyer ES, Ensrud KE, et al. Fracture risk in diabetic elderly men: the 
MrOS study. Diabetologia. Oct 2014;57(10):2057-2065. 
29. Strotmeyer ES, Cauley JA, Schwartz AV, et al. Nontraumatic fracture risk with diabetes 
mellitus and impaired fasting glucose in older white and black adults: the health, aging, 
and body composition study. Arch. Intern. Med. Jul 25 2005;165(14):1612-1617. 
30. Yamaguchi T, Sugimoto T. Bone metabolism and fracture risk in type 2 diabetes mellitus 
[Review]. Endocr. J. 2011;58(8):613-624. 
31. Pijpers E, Ferreira I, de Jongh RT, et al. Older individuals with diabetes have an 
increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal 
Ageing Study Amsterdam. Age Ageing. May 2012;41(3):358-365. 
32. Chiles NS, Phillips CL, Volpato S, et al. Diabetes, peripheral neuropathy, and lower-
extremity function. J. Diabetes Complications. Jan-Feb 2014;28(1):91-95. 
33. Fife TD. Benign paroxysmal positional vertigo. Semin. Neurol. Nov 2009;29(5):500-508. 
34. Mirka A, Black FO. Clinical application of dynamic posturography for evaluating 
sensory integration and vestibular dysfunction. Neurol. Clin. May 1990;8(2):351-359. 
35. Myers SF, Ross MD. Morphological evidence of vestibular pathology in long-term 
experimental diabetes mellitus. II. Connective tissue and neuroepithelial pathology. Acta 
Otolaryngol. Jul-Aug 1987;104(1-2):40-49. 
36. Myers SF, Tormey MC, Akl S. Morphometric analysis of horizontal canal nerves of 
chronically diabetic rats. Otolaryngol. Head Neck Surg. Feb 1999;120(2):174-179. 
37. Perez R, Ziv E, Freeman S, Sichel JY, Sohmer H. Vestibular end-organ impairment in an 
animal model of type 2 diabetes mellitus. Laryngoscope. Jan 2001;111(1):110-113. 
121 
 
38. Rybak LP. Metabolic disorders of the vestibular system. Otolaryngol. Head Neck Surg. 
Jan 1995;112(1):128-132. 
39. Klagenberg KF, Zeigelboim BS, Jurkiewicz AL, Martins-Bassetto J. Vestibulocochlear 
manifestations in patients with type I diabetes mellitus. Braz. J. Otorhinolaryngol. May-
Jun 2007;73(3):353-358. 
40. Biurrun O, Ferrer JP, Lorente J, De Espana R, Gomis R, Traserra J. Asymptomatic 
electronystagmographic abnormalities in patients with type I diabetes mellitus. ORL J. 
Otorhinolaryngol. Relat. Spec. 1991;53(6):335-338. 
41. Nicholson M, King J, Smith PF, Darlington CL. Vestibulo-ocular, optokinetic and 
postural function in diabetes mellitus. Neuroreport. Jan 21 2002;13(1):153-157. 
42. Chavez-Delgado ME, Vazquez-Granados I, Rosales-Cortes M, Velasco-Rodriguez V. 
[Cochleovestibular dysfunction in patients with diabetes mellitus, hypertension and 
dyslipidemia]. Acta Otorrinolaringol. Esp. Mar 2012;63(2):93-101. 
43. Cohen HS, Kimball KT, Stewart MG. Benign paroxysmal positional vertigo and 
comorbid conditions. ORL J. Otorhinolaryngol. Relat. Spec. 2004;66(1):11-15. 
44. Kim SK, Lee KJ, Hahm JR, et al. Clinical significance of the presence of autonomic and 
vestibular dysfunction in diabetic patients with peripheral neuropathy. Diabetes Metab. J. 
Feb 2012;36(1):64-69. 
45. De Stefano A, Dispenza F, Suarez H, et al. A multicenter observational study on the role 
of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris 
Nasus Larynx. Aug 6 2013. 
122 
 
46. Jacobson GP, McCaslin DL, Piker EG, Gruenwald J, Grantham S, Tegel L. Insensitivity 
of the "Romberg test of standing balance on firm and compliant support surfaces" to the 
results of caloric and VEMP tests. Ear Hear. Nov-Dec 2011;32(6):e1-5. 
47. Degerman E, Rauch U, Lindberg S, Caye-Thomasen P, Hultgardh A, Magnusson M. 
Expression of insulin signalling components in the sensory epithelium of the human 
saccule. Cell Tissue Res. Jun 2013;352(3):469-478. 
48. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid 
metabolism. Nature. Dec 13 2001;414(6865):799-806. 
49. Yoda S, Cureoglu S, Yildirim-Baylan M, et al. Association between type 1 diabetes 
mellitus and deposits in the semicircular canals. Otolaryngol. Head Neck Surg. Sep 
2011;145(3):458-462. 
50. De Stefano A, Dispenza F, Suarez H, et al. A multicenter observational study on the role 
of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris 
Nasus Larynx. Feb 2014;41(1):31-36. 
51. Prokopakis E, Vlastos IM, Tsagournisakis M, Christodoulou P, Kawauchi H, Velegrakis 
G. Canalith repositioning procedures among 965 patients with benign paroxysmal 
positional vertigo. Audiol. Neurootol. 2013;18(2):83-88. 
52. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic 
control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical 
trials. JAMA. Sep 12 2001;286(10):1218-1227. 
53. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD. Physical 
activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes 
Association. Diabetes Care. Jun 2006;29(6):1433-1438. 
123 
 
54. Standards of Medical Care in Diabetes-2015. Diabetes Care. 2015;38, Suppl 1. 
55. Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. 
Arch. Otolaryngol. Head Neck Surg. Apr 1990;116(4):424-427. 
56. Whitney SL, Wrisley DM, Brown KE, Furman JM. Is perception of handicap related to 
functional performance in persons with vestibular dysfunction? Otol. Neurotol. Mar 
2004;25(2):139-143. 
57. Myers AM, Fletcher PC, Myers AH, Sherk W. Discriminative and evaluative properties 
of the activities-specific balance confidence (ABC) scale. J. Gerontol. A Biol. Sci. Med. 
Sci. Jul 1998;53(4):M287-294. 
58. Lajoie Y, Gallagher SP. Predicting falls within the elderly community: comparison of 
postural sway, reaction time, the Berg balance scale and the Activities-specific Balance 
Confidence (ABC) scale for comparing fallers and non-fallers. Arch. Gerontol. Geriatr. 
Jan-Feb 2004;38(1):11-26. 
59. Yardley L, Masson E, Verschuur C, Haacke N, Luxon L. Symptoms, anxiety and 
handicap in dizzy patients: development of the vertigo symptom scale. J. Psychosom. 
Res. Dec 1992;36(8):731-741. 
60. Murray KJ, Hill KD, Phillips B, Waterston J. The influence of otolith dysfunction on the 
clinical presentation of people with a peripheral vestibular disorder. Phys. Ther. Feb 
2007;87(2):143-152. 
61. McCaslin DL, Jacobson GP, Grantham SL, Piker EG, Verghese S. The influence of 
unilateral saccular impairment on functional balance performance and self-report 
dizziness. J. Am. Acad. Audiol. Sep 2011;22(8):542-549; quiz 560-541. 
124 
 
62. Shumway-Cook A, Horak FB. Assessing the influence of sensory interaction of balance. 
Suggestion from the field. Phys. Ther. Oct 1986;66(10):1548-1550. 
63. Jernigan SD, Pohl PS, Mahnken JD, Kluding PM. Diagnostic accuracy of fall risk 
assessment tools in people with diabetic peripheral neuropathy. Phys. Ther. Nov 
2012;92(11):1461-1470. 
64. Wrisley DM, Kumar NA. Functional gait assessment: concurrent, discriminative, and 
predictive validity in community-dwelling older adults. Phys. Ther. May 2010;90(5):761-
773. 
65. Herdman S. Vestibular Rehabilitation, 2nd edition2000. 
66. Oghalai JS, Manolidis S, Barth JL, Stewart MG, Jenkins HA. Unrecognized benign 
paroxysmal positional vertigo in elderly patients. Otolaryngol. Head Neck Surg. May 
2000;122(5):630-634. 
67. Bhattacharyya N, Baugh RF, Orvidas L, et al. Clinical practice guideline: benign 
paroxysmal positional vertigo. Otolaryngol. Head Neck Surg. Nov 2008;139(5 Suppl 
4):S47-81. 
68. Feldman EL, Stevens MJ. Clinical testing in diabetic peripheral neuropathy. Can. J. 
Neurol. Sci. Nov 1994;21(4):S3-7. 
69. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening 
instrument for diabetic peripheral neuropathy. Clin. Neurol. Neurosurg. Jul 
2006;108(5):477-481. 
70. Zelman DC, Gore M, Dukes E, Tai KS, Brandenburg N. Validation of a modified version 
of the brief pain inventory for painful diabetic peripheral neuropathy. J. Pain Symptom 
Manage. Apr 2005;29(4):401-410. 
125 
 
71. Hall CD, Schubert MC, Herdman SJ. Prediction of fall risk reduction as measured by 
dynamic gait index in individuals with unilateral vestibular hypofunction. Otol. Neurotol. 
Sep 2004;25(5):746-751. 
72. Korres S, Balatsouras DG, Ferekidis E. Prognosis of patients with benign paroxysmal 
positional vertigo treated with repositioning manoeuvres. J. Laryngol. Otol. Jul 
2006;120(7):528-533. 
73. Kluding PM, Pasnoor M, Singh R, et al. The effect of exercise on neuropathic symptoms, 
nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. 
J. Diabetes Complications. Sep-Oct 2012;26(5):424-429. 
74. Morrison S, Colberg SR, Parson HK, Vinik AI. Exercise improves gait, reaction time and 
postural stability in older adults with type 2 diabetes and neuropathy. J. Diabetes 
Complications. Sep-Oct 2014;28(5):715-722. 
75. Reid RD, Tulloch HE, Sigal RJ, et al. Effects of aerobic exercise, resistance exercise or 
both, on patient-reported health status and well-being in type 2 diabetes mellitus: a 
randomised trial. Diabetologia. Apr 2010;53(4):632-640. 
76. Kruse RL, Lemaster JW, Madsen RW. Fall and balance outcomes after an intervention to 
promote leg strength, balance, and walking in people with diabetic peripheral neuropathy: 
"feet first" randomized controlled trial. Phys. Ther. Nov 2010;90(11):1568-1579. 
77. Allet L, Armand S, de Bie RA, et al. The gait and balance of patients with diabetes can be 
improved: a randomised controlled trial. Diabetologia. Mar 2010;53(3):458-466. 
78. Rucker JL, Jernigan SD, McDowd JM, Kluding PM. Adults With Diabetic Peripheral 
Neuropathy Exhibit Impairments in Multitasking and Other Executive Functions. J. 
Neurol. Phys. Ther. Dec 31 2013. 
126 
 
79. Tilling LM, Darawil K, Britton M. Falls as a complication of diabetes mellitus in older 
people. J. Diabetes Complications. May-Jun 2006;20(3):158-162. 
80. Wallace C, Reiber GE, LeMaster J, et al. Incidence of falls, risk factors for falls, and fall-
related fractures in individuals with diabetes and a prior foot ulcer. Diabetes Care. Nov 
2002;25(11):1983-1986. 
81. Richardson JK, Sandman D, Vela S. A focused exercise regimen improves clinical 
measures of balance in patients with peripheral neuropathy. Arch. Phys. Med. Rehabil. 
Feb 2001;82(2):205-209. 
82. Morrison S, Colberg SR, Mariano M, Parson HK, Vinik AI. Balance training reduces 
falls risk in older individuals with type 2 diabetes. Diabetes Care. Apr 2010;33(4):748-
750. 
83. Ahn S, Song R. Effects of Tai Chi Exercise on glucose control, neuropathy scores, 
balance, and quality of life in patients with type 2 diabetes and neuropathy. J. Altern. 
Complement. Med. Dec 2012;18(12):1172-1178. 
84. Salsabili H, Bahrpeyma F, Forogh B, Rajabali S. Dynamic stability training improves 
standing balance control in neuropathic patients with type 2 diabetes. J. Rehabil. Res. 
Dev. 2011;48(7):775-786. 
85. Song CH, Petrofsky JS, Lee SW, Lee KJ, Yim JE. Effects of an exercise program on 
balance and trunk proprioception in older adults with diabetic neuropathies. Diabetes 
Technol. Ther. Aug 2011;13(8):803-811. 
86. Morrison S, Colberg SR, Parson HK, Vinik AI. Relation between risk of falling and 
postural sway complexity in diabetes. Gait Posture. Apr 2012;35(4):662-668. 
127 
 
87. Mueller MJ, Tuttle LJ, Lemaster JW, et al. Weight-bearing versus nonweight-bearing 
exercise for persons with diabetes and peripheral neuropathy: a randomized controlled 
trial. Arch. Phys. Med. Rehabil. May 2013;94(5):829-838. 
88. von Brevern M, Radtke A, Lezius F, et al. Epidemiology of benign paroxysmal positional 
vertigo: a population based study. J. Neurol. Neurosurg. Psychiatry. Jul 2007;78(7):710-
715. 
89. Korres SG, Balatsouras DG, Papouliakos S, Ferekidis E. Benign paroxysmal positional 
vertigo and its management. Med. Sci. Monit. Jun 2007;13(6):CR275-282. 
90. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal 
positional vertigo. Otolaryngol. Head Neck Surg. Sep 1992;107(3):399-404. 
91. Baloh RW, Honrubia V, Jacobson K. Benign positional vertigo: clinical and oculographic 
features in 240 cases. Neurology. Mar 1987;37(3):371-378. 
92. Ishiyama A, Jacobson KM, Baloh RW. Migraine and benign positional vertigo. Ann. 
Otol. Rhinol. Laryngol. Apr 2000;109(4):377-380. 
93. Lempert T, Leopold M, von Brevern M, Neuhauser H. Migraine and benign positional 
vertigo. Ann. Otol. Rhinol. Laryngol. Dec 2000;109(12 Pt 1):1176. 
94. Vibert D, Kompis M, Hausler R. Benign paroxysmal positional vertigo in older women 
may be related to osteoporosis and osteopenia. Ann. Otol. Rhinol. Laryngol. Oct 
2003;112(10):885-889. 
95. von Brevern M, Neuhauser H. Epidemiological evidence for a link between vertigo and 
migraine. J. Vestib. Res. 2011;21(6):299-304. 
128 
 
96. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with 
macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): 
prospective observational study. BMJ. Aug 12 2000;321(7258):412-419. 
97. Tight blood pressure control and risk of macrovascular and microvascular complications 
in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. Sep 12 
1998;317(7160):703-713. 
98. Warninghoff JC, Bayer O, Ferrari U, Straube A. Co-morbidities of vertiginous diseases. 
BMC Neurol. 2009;9:29. 
99. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates 
for the year 2000 and projections for 2030. Diabetes Care. May 2004;27(5):1047-1053. 
100. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of Diabetes and 
Diabetes-Related Complications. Phys. Ther. November 2008 2008;88(11):1254-1264. 
101. Lawson J, Johnson I, Bamiou DE, Newton JL. Benign paroxysmal positional vertigo: 
clinical characteristics of dizzy patients referred to a Falls and Syncope Unit. QJM. May 
2005;98(5):357-364. 
102. Waitman LR, Warren JJ, Manos EL, Connolly DW. Expressing observations from 
electronic medical record flowsheets in an i2b2 based clinical data repository to support 
research and quality improvement. AMIA Annu Symp Proc. 2011;2011:1454-1463. 
103. Murphy SN, Weber G, Mendis M, et al. Serving the enterprise and beyond with 




104. Baron RM, Kenny DA. The moderator-mediator variable distinction in social 
psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. 
Psychol. Dec 1986;51(6):1173-1182. 
105. Epstein M. Diabetes and hypertension: the bad companions. J. Hypertens. Suppl. Mar 
1997;15(2):S55-62. 
106. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. 
Circulation. Sep 13 2005;112(11):1651-1662. 
107. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 
Aug 11 2012;380(9841):601-610. 
108. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. 
Diabetologia. Feb 2001;44(2):129-146. 
109. Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular 
complications. Diabet. Med. Dec 2001;18(12):945-959. 
110. de Moraes Marchiori LL, de Almeida Rego Filho E, Matsuo T. Hypertension as a factor 
associated with hearing loss. Braz. J. Otorhinolaryngol. Jul-Aug 2006;72(4):533-540. 
111. Maia CA, Campos CA. Diabetes mellitus as etiological factor of hearing loss. Braz. J. 
Otorhinolaryngol. Mar-Apr 2005;71(2):208-214. 
112. Wada M, Naganuma H, Tokumasu K, Hashimoto S, Ito A, Okamoto M. Arteriosclerotic 
changes as background factors in patients with peripheral vestibular disorders. Int 
Tinnitus J. 2008;14(2):131-134. 
113. Zhang D, Zhang S, Zhang H, et al. Evaluation of vertebrobasilar artery changes in 




114. Kao CL, Cheng YY, Leu HB, et al. Increased risk of ischemic stroke in patients with 
benign paroxysmal positional vertigo: a 9-year follow-up nationwide population study in 
taiwan. Front. Aging Neurosci. 2014;6:108. 
115. Jang YS, Hwang CH, Shin JY, Bae WY, Kim LS. Age-related changes on the 
morphology of the otoconia. Laryngoscope. Jun 2006;116(6):996-1001. 
116. Lee SH, Kim JS. Benign paroxysmal positional vertigo. J. Clin. Neurol. Jun 
2010;6(2):51-63. 
117. CDC. National Diabetes Fact sheet. 2011. 
118. Shah A, Kanaya AM. Diabetes and associated complications in the South Asian 
population. Curr. Cardiol. Rep. May 2014;16(5):476. 
119. van Leeuwen RB, van der Zaag-Loonen H. Referrals to a specialised dizziness clinic 
often result in revised diagnoses and new therapeutic advice. Eur. Neurol. 2015;73(1-
2):20-22. 
120. Whitney SL, Marchetti GF, Morris LO. Usefulness of the dizziness handicap inventory in 
the screening for benign paroxysmal positional vertigo. Otol. Neurotol. Sep 
2005;26(5):1027-1033. 
121. Brown SJ, Handsaker JC, Bowling FL, Boulton AJ, Reeves ND. Diabetic peripheral 
neuropathy compromises balance during daily activities. Diabetes Care. Jun 
2015;38(6):1116-1122. 
122. Ward BK, Agrawal Y, Hoffman HJ, Carey JP, Della Santina CC. Prevalence and impact 
of bilateral vestibular hypofunction: results from the 2008 US National Health Interview 
Survey. JAMA Otolaryngol Head Neck Surg. Aug 1 2013;139(8):803-810. 
131 
 
123. Ward BK, Wenzel A, Kalyani RR, et al. Characterization of Vestibulopathy in 
Individuals with Type 2 Diabetes Mellitus. Otolaryngol. Head Neck Surg. Jul 
2015;153(1):112-118. 
124. Konukseven O, Polat SB, Karahan S, et al. Electrophysiologic vestibular evaluation in 
type 2 diabetic and prediabetic patients: Air conduction ocular and cervical vestibular 
evoked myogenic potentials. Int. J. Audiol. Dec 22 2014:1-8. 
125. Smith TL, Raynor E, Prazma J, Buenting JE, Pillsbury HC. Insulin-dependent diabetic 
microangiopathy in the inner ear. Laryngoscope. Mar 1995;105(3 Pt 1):236-240. 
126. Wada M, Naganuma H, Tokumasu K, Ito A, Okamoto M. Inner-ear function test in cases 
of posterior canal-type benign paroxysmal positional vertigo. Int Tinnitus J. 
2009;15(1):91-93. 
127. von Brevern M, Schmidt T, Schonfeld U, Lempert T, Clarke AH. Utricular dysfunction 
in patients with benign paroxysmal positional vertigo. Otol. Neurotol. Jan 2006;27(1):92-
96. 
128. Rosengren SM, Welgampola MS, Colebatch JG. Vestibular evoked myogenic potentials: 
past, present and future. Clin. Neurophysiol. May 2010;121(5):636-651. 
129. Akin FW, Murnane OD, Panus PC, Caruthers SK, Wilkinson AE, Proffitt TM. The 
influence of voluntary tonic EMG level on the vestibular-evoked myogenic potential. J. 
Rehabil. Res. Dev. May 2004;41(3B):473-480. 
130. Colebatch JG, Halmagyi GM, Skuse NF. Myogenic potentials generated by a click-
evoked vestibulocollic reflex. J. Neurol. Neurosurg. Psychiatry. Feb 1994;57(2):190-197. 
132 
 
131. Curthoys IS, Iwasaki S, Chihara Y, Ushio M, McGarvie LA, Burgess AM. The ocular 
vestibular-evoked myogenic potential to air-conducted sound; probable superior 
vestibular nerve origin. Clin. Neurophysiol. Mar 2011;122(3):611-616. 
132. Rosengren SM, Aw ST, Halmagyi GM, Todd NP, Colebatch JG. Ocular vestibular 
evoked myogenic potentials in superior canal dehiscence. J. Neurol. Neurosurg. 
Psychiatry. May 2008;79(5):559-568. 
133. Hong SM, Yeo SG, Kim SW, Cha CI. The results of vestibular evoked myogenic 
potentials, with consideration of age-related changes, in vestibular neuritis, benign 
paroxysmal positional vertigo, and Meniere's disease. Acta Otolaryngol. Aug 
2008;128(8):861-865. 
134. Korres S, Gkoritsa E, Giannakakou-Razelou D, Yiotakis I, Riga M, Nikolpoulos TP. 
Vestibular evoked myogenic potentials in patients with BPPV. Med. Sci. Monit. Jan 
2011;17(1):CR42-47. 
135. Akkuzu G, Akkuzu B, Ozluoglu LN. Vestibular evoked myogenic potentials in benign 
paroxysmal positional vertigo and Meniere's disease. Eur. Arch. Otorhinolaryngol. Jun 
2006;263(6):510-517. 
136. Yang WS, Kim SH, Lee JD, Lee WS. Clinical significance of vestibular evoked 
myogenic potentials in benign paroxysmal positional vertigo. Otol. Neurotol. Dec 
2008;29(8):1162-1166. 
137. Nakahara H, Yoshimura E, Tsuda Y, Murofushi T. Damaged utricular function clarified 




138. Lee JD, Park MK, Lee BD, Lee TK, Sung KB, Park JY. Abnormality of cervical 
vestibular-evoked myogenic potentials and ocular vestibular-evoked myogenic potentials 
in patients with recurrent benign paroxysmal postitional vertigo. Acta Otolaryngol. Feb 
2013;133(2):150-153. 
139. Seo T, Saka N, Ohta S, Sakagami M. Detection of utricular dysfunction using ocular 
vestibular evoked myogenic potential in patients with benign paroxysmal positional 
vertigo. Neurosci. Lett. Aug 29 2013;550:12-16. 
140. Kamali B, Hajiabolhassan F, Fatahi J, Nasli Esfahani E, Sarrafzadeh J, Faghihzadeh S. 
Effects of diabetes mellitus type Iota with or without neuropathy on vestibular evoked 
myogenic potentials. Acta Med. Iran. 2013;51(2):107-112. 
141. Bektas D, Gazioglu S, Arslan S, Cobanoglu B, Boz C, Caylan R. VEMP responses are 
not affected in non-insulin-dependent diabetes mellitus patients with or without 
polyneuropathy. Acta Otolaryngol. Jul 2008;128(7):768-771. 
142. Vanspauwen R, Wuyts FL, Van De Heyning PH. Validity of a new feedback method for 
the VEMP test. Acta Otolaryngol. Aug 2006;126(8):796-800. 
143. Tourtillott BM, Ferraro JA, Bani-Ahmed A, Almquist E, Deshpande N. Age-related 
changes in vestibular evoked myogenic potentials using a modified blood pressure 
manometer feedback method. Am J Audiol. Dec 2010;19(2):100-108. 
144. Rosengren SM, Govender S, Colebatch JG. Ocular and cervical vestibular evoked 
myogenic potentials produced by air- and bone-conducted stimuli: comparative 
properties and effects of age. Clin. Neurophysiol. Nov 2011;122(11):2282-2289. 
134 
 
145. Hong SM, Park DC, Yeo SG, Cha CI. Vestibular evoked myogenic potentials in patients 
with benign paroxysmal positional vertigo involving each semicircular canal. Am. J. 
Otolaryngol. May-Jun 2008;29(3):184-187. 
146. Longo G, Onofri M, Pellicciari T, Quaranta N. Benign paroxysmal positional vertigo: is 
vestibular evoked myogenic potential testing useful? Acta Otolaryngol. Jan 
2012;132(1):39-43. 
147. Akin FW, Murnane OD, Tampas JW, Clinard CG. The effect of age on the vestibular 
evoked myogenic potential and sternocleidomastoid muscle tonic electromyogram level. 
Ear Hear. Sep-Oct 2011;32(5):617-622. 
148. Kim EJ, Oh SY, Kim JS, Yang TH, Yang SY. Persistent otolith dysfunction even after 
successful repositioning in benign paroxysmal positional vertigo. J. Neurol. Sci. Sep 5 
2015. 
149. Giacomini PG, Alessandrini M, Magrini A. Long-term postural abnormalities in benign 
paroxysmal positional vertigo. ORL J. Otorhinolaryngol. Relat. Spec. Jul-Aug 
2002;64(4):237-241. 
150. Saxena A, Prabhakar MC. Performance of DHI score as a predictor of benign paroxysmal 
positional vertigo in geriatric patients with dizziness/vertigo: a cross-sectional study. 
PLoS One. 2013;8(3):e58106. 
151. D'Silva LJ, Lin J, Staecker H, Whitney SL, Kluding PM. Impact of Diabetic 
Complications on Balance and Falls: Contribution of the Vestibular System. Phys. Ther. 
Aug 6 2015. 
152. Hall SF, Ruby RR, McClure JA. The mechanics of benign paroxysmal vertigo. J. 
Otolaryngol. Apr 1979;8(2):151-158. 
135 
 
153. Schuknecht HF. Cupulolithiasis. Arch. Otolaryngol. Dec 1969;90(6):765-778. 
154. Blatt PJ, Georgakakis GA, Herdman SJ, Clendaniel RA, Tusa RJ. The effect of the 
canalith repositioning maneuver on resolving postural instability in patients with benign 
paroxysmal positional vertigo. Am. J. Otol. May 2000;21(3):356-363. 
155. Dix MR, Hallpike CS. The pathology symptomatology and diagnosis of certain common 
disorders of the vestibular system. Proc. R. Soc. Med. Jun 1952;45(6):341-354. 
156. Gananca FF, Gazzola JM, Gananca CF, Caovilla HH, Gananca MM, Cruz OL. Elderly 
falls associated with benign paroxysmal positional vertigo. Braz. J. Otorhinolaryngol. 
Jan-Feb 2010;76(1):113-120. 
157. Celebisoy N, Bayam E, Gulec F, Kose T, Akyurekli O. Balance in posterior and 
horizontal canal type benign paroxysmal positional vertigo before and after canalith 
repositioning maneuvers. Gait Posture. Apr 2009;29(3):520-523. 
158. Chang WC, Hsu LC, Yang YR, Wang RY. Balance ability in patients with benign 
paroxysmal positional vertigo. Otolaryngol. Head Neck Surg. Oct 2006;135(4):534-540. 
159. dos Santos MJ, Gorges AL, Rios JL. Individuals with chronic ankle instability exhibit 
decreased postural sway while kicking in a single-leg stance. Gait Posture. 
2014;40(1):231-236. 
160. Horak FB, Dickstein R, Peterka RJ. Diabetic neuropathy and surface sway-referencing 
disrupt somatosensory information for postural stability in stance. Somatosens. Mot. Res. 
2002;19(4):316-326. 
161. Horak FB, Nashner LM, Diener HC. Postural strategies associated with somatosensory 
and vestibular loss. Exp. Brain Res. 1990;82(1):167-177. 
136 
 
162. Prieto TE, Myklebust JB, Hoffmann RG, Lovett EG, Myklebust BM. Measures of 
postural steadiness: differences between healthy young and elderly adults. IEEE Trans. 
Biomed. Eng. Sep 1996;43(9):956-966. 
163. Uccioli L, Giacomini PG, Monticone G, et al. Body sway in diabetic neuropathy. 
Diabetes Care. Mar 1995;18(3):339-344. 
164. Huisinga JM, Yentes JM, Filipi ML, Stergiou N. Postural control strategy during standing 
is altered in patients with multiple sclerosis. Neurosci. Lett. Aug 30 2012;524(2):124-
128. 
165. Liu W, Santos MJ, McIntire K, Loudon J, Goist-Foley H, Horton G. Patterns of inter-
joint coordination during a single-limb standing. Gait Posture. Jul 2012;36(3):614-618. 
166. Piirtola M, Era P. Force platform measurements as predictors of falls among older people 
- a review. Gerontology. 2006;52(1):1-16. 
167. Marchetti GF, Bellanca J, Whitney SL, et al. The development of an accelerometer-based 
measure of human upright static anterior- posterior postural sway under various sensory 
conditions: Test-retest reliability, scoring and preliminary validity of the Balance 
Accelerometry Measure (BAM). J. Vestib. Res. Jan 1 2013;23(4):227-235. 
168. Huisinga JM, Mancini M, St George RJ, Horak FB. Accelerometry reveals differences in 
gait variability between patients with multiple sclerosis and healthy controls. Ann. 
Biomed. Eng. Aug 2013;41(8):1670-1679. 
169. Moe-Nilssen R, Helbostad JL. Trunk accelerometry as a measure of balance control 
during quiet standing. Gait Posture. Aug 2002;16(1):60-68. 
137 
 
170. Najafi B, Horn D, Marclay S, Crews RT, Wu S, Wrobel JS. Assessing postural control 
and postural control strategy in diabetes patients using innovative and wearable 
technology. J Diabetes Sci Technol. Jul 2010;4(4):780-791. 
171. Whitney SL, Roche JL, Marchetti GF, et al. A comparison of accelerometry and center of 
pressure measures during computerized dynamic posturography: a measure of balance. 
Gait Posture. Apr 2011;33(4):594-599. 
172. Rine RM, Schubert MC, Whitney SL, et al. Vestibular function assessment using the NIH 
Toolbox. Neurology. Mar 12 2013;80(11 Suppl 3):S25-31. 
173. Kamen G, Patten C, Du CD, Sison S. An accelerometry-based system for the assessment 
of balance and postural sway. Gerontology. 1998;44(1):40-45. 
174. O'Sullivan M, Blake C, Cunningham C, Boyle G, Finucane C. Correlation of 
accelerometry with clinical balance tests in older fallers and non-fallers. Age Ageing. 
May 2009;38(3):308-313. 
175. Mancini M, Salarian A, Carlson-Kuhta P, et al. ISway: a sensitive, valid and reliable 
measure of postural control. J. Neuroeng. Rehabil. 2012;9:59. 
176. Whitney SL, Wrisley DM. The influence of footwear on timed balance scores of the 
modified clinical test of sensory interaction and balance. Arch. Phys. Med. Rehabil. Mar 
2004;85(3):439-443. 
177. Herdman SJ. Vestibular rehabilitation. Curr. Opin. Neurol. Feb 2013;26(1):96-101. 
178. Akin FW, Murnane OD. Vestibular evoked myogenic potentials: preliminary report. J. 
Am. Acad. Audiol. Oct 2001;12(9):445-452; quiz 491. 
138 
 
179. Serrador JM, Lipsitz LA, Gopalakrishnan GS, Black FO, Wood SJ. Loss of otolith 
function with age is associated with increased postural sway measures. Neurosci. Lett. 
Nov 6 2009;465(1):10-15. 
180. Vereeck L, Wuyts FL, Truijen S, De Valck C, Van de Heyning PH. The effect of early 
customized vestibular rehabilitation on balance after acoustic neuroma resection. Clin. 
Rehabil. Aug 2008;22(8):698-713. 
181. Di Nardo W, Ghirlanda G, Cercone S, et al. The use of dynamic posturography to detect 
neurosensorial disorder in IDDM without clinical neuropathy. J. Diabetes Complications. 
Mar-Apr 1999;13(2):79-85. 
182. Dyck PJ, Albers JW, Andersen H, et al. Diabetic polyneuropathies: update on research 
definition, diagnostic criteria and estimation of severity. Diabetes Metab. Res. Rev. Oct 
2011;27(7):620-628. 
183. Whitney SL, Marchetti GF, Schade A, Wrisley DM. The sensitivity and specificity of the 
Timed "Up & Go" and the Dynamic Gait Index for self-reported falls in persons with 
vestibular disorders. J. Vestib. Res. 2004;14(5):397-409. 
184. Whitney S, Wrisley D, Furman J. Concurrent validity of the Berg Balance Scale and the 
Dynamic Gait Index in people with vestibular dysfunction. Physiother. Res. Int. 
2003;8(4):178-186. 
185. Dutil M, Handrigan GA, Corbeil P, et al. The impact of obesity on balance control in 




186. Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with 
type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes 
Metab. Syndr. Obes. 2013;6:327-338. 
187. Benecke H, Agus S, Kuessner D, Goodall G, Strupp M. The Burden and Impact of 
Vertigo: Findings from the REVERT Patient Registry. Front. Neurol. 2013;4:136. 
188. Friscia LA, Morgan MT, Sparto PJ, Furman JM, Whitney SL. Responsiveness of self-
report measures in individuals with vertigo, dizziness, and unsteadiness. Otol. Neurotol. 
Jun 2014;35(5):884-888. 
189. Wrisley DM, Marchetti GF, Kuharsky DK, Whitney SL. Reliability, internal consistency, 
and validity of data obtained with the functional gait assessment. Phys. Ther. Oct 
2004;84(10):906-918. 
190. Kasse CA, Santana GG, Scharlach RC, Gazzola JM, Branco FC, Dona F. Results from 
the balance rehabilitation unit in benign paroxysmal positional vertigo. Braz. J. 
Otorhinolaryngol. Sep-Oct 2010;76(5):623-629. 
191. Silva CN, Ribeiro KM, Freitas RV, Ferreira LM, Guerra RO. Vertiginous Symptoms and 
Objective Measures of Postural Balance in Elderly People with Benign Paroxysmal 
Positional Vertigo Submitted to the Epley Maneuver. International archives of 
otorhinolaryngology. Jan 2016;20(1):61-68. 
192. Lee NH, Kwon HJ, Ban JH. Analysis of residual symptoms after treatment in benign 




193. Di Girolamo S, Paludetti G, Briglia G, Cosenza A, Santarelli R, Di Nardo W. Postural 
control in benign paroxysmal positional vertigo before and after recovery. Acta 
Otolaryngol. Jun 1998;118(3):289-293. 
194. Chang WC, Yang YR, Hsu LC, Chern CM, Wang RY. Balance improvement in patients 
with benign paroxysmal positional vertigo. Clin. Rehabil. Apr 2008;22(4):338-347. 
195. Fife D, FitzGerald JE. Do patients with benign paroxysmal positional vertigo receive 
prompt treatment? Analysis of waiting times and human and financial costs associated 
with current practice. Int. J. Audiol. Jan 2005;44(1):50-57. 
196. Singleton JR, Marcus RL, Lessard MK, Jackson JE, Smith AG. Supervised exercise 
improves cutaneous reinnervation capacity in metabolic syndrome patients. Ann. Neurol. 
Jan 2015;77(1):146-153. 
197. Lee SK, Kim SJ, Park MS, Byun JY. Otolith organ function according to subtype of 
benign paroxysmal positional vertigo. Laryngoscope. Apr 2014;124(4):984-988. 
198. Kerber KA, Burke JF, Skolarus LE, et al. Use of BPPV processes in emergency 
department dizziness presentations: a population-based study. Otolaryngol. Head Neck 
Surg. Mar 2013;148(3):425-430. 
  
   
